<!DOCTYPE html>
<!--[if IEMobile 7 ]>    <html class="no-js iem7"> <![endif]-->
<!--[if (gt IEMobile 7)|!(IEMobile)]><!-->
<html class="no-js" xmlns="http://www.w3.org/1999/xhtml">
  <!--<![endif]-->

  <head>
    <meta name="generator" content="HTML Tidy for Linux/x86 (vers 25 March 2009), see www.w3.org" />
    <meta charset="utf-8" />
    <title>Special Blood Request</title>
    <meta name="description" content="Learn about, look up and test your knowledge of the indications for irradiated and cytomegalovirus (CMV) negative blood components." />
    <meta name="HandheldFriendly" content="True" />
    <meta name="MobileOptimized" content="320" />
    <meta name="viewport" content="width=device-width, initial-scale=1" />
    <meta http-equiv="cleartype" content="on" />
    <link rel="apple-touch-icon-precomposed" sizes="144x144" href="logo.png" />
    <link rel="apple-touch-icon-precomposed" sizes="114x114" href="logo.png" />
    <link rel="apple-touch-icon-precomposed" sizes="72x72" href="logo.png" />
    <link rel="apple-touch-icon-precomposed" href="logo.png" />
    <link rel="shortcut icon" href="logo.png" />
    <!-- Tile icon for Win8 (144x144 + tile color) -->
    <meta name="msapplication-TileImage" content="logo.png" />
    <meta name="msapplication-TileColor" content="#222222" />
    <!-- For iOS web apps. Delete if not needed. https://github.com/h5bp/mobile-boilerplate/issues/94 -->
    <meta name="apple-mobile-web-app-capable" content="yes" />
    <meta name="apple-mobile-web-app-status-bar-style" content="black" />
    <meta name="apple-mobile-web-app-title" content="Special Blood Request" />
    <script type='text/javascript' src='//code.jquery.com/jquery-1.9.1.js'></script>
    <script type='text/javascript' src="http://knockoutjs.com/downloads/knockout-3.0.0.js"></script>
    <script type='text/javascript' src="http://code.jquery.com/mobile/1.4.2/jquery.mobile-1.4.2.min.js"></script>
    <link rel="stylesheet" type="text/css" href="http://code.jquery.com/mobile/1.4.2/jquery.mobile-1.4.2.min.css">
    <link rel="stylesheet" href="themes/specialcomponents142.css" type="text/css" />
    <style type="text/css">
      /*<![CDATA[*/
      /* Restrict max page width to look better on desktops,
           yet use resolution of ipad (1024 wide). */
      .ui-page {
        max-width: 1000px !important;
        margin: 0 auto !important;
        position: relative !important;
        border: 1px solid #aaa !important;
      }
      /* Make text more readable on high resolution devices */
      .ui-content {
        max-width: 800px;
        margin: auto;
      }
      /* Allow line wrapping on buttons and list items */
      .ui-li .ui-btn-text a.ui-link-inherit {
        white-space: normal;
      }
      .ui-header .ui-title,
      .ui-footer .ui-title {
        white-space: normal;
      }
      .ui-btn-inner {
        white-space: normal;
      }
      /* Reduce button padding to fit small resolutions */
      a.ui-btn-icon-top .ui-btn-inner {
        padding-left: 2px;
        padding-right: 2px;
      }
      a.ui-btn-icon-left .ui-btn-inner {
        padding: 0.55em 2px 0.5em 32px;
      }
      a.ui-btn-icon-right .ui-btn-inner {
        padding: 0.55em 32px 0.5em 2px;
      }
      /* Improve smart bar grid layout |-a-|---b---| */
      .ui-grid-a > .ui-block-a.custom {
        width: 30%;
        min-width: 100px;
      }
      .ui-grid-a > .ui-block-b.custom {
        width: 65%;
      }
      /* Style inline reference links */
      .ui-header .ui-btn-inner,
      .ui-footer .ui-btn-inner,
      .ui-mini .ui-btn-inner {
        padding: 6px;
        margin: 0px;
        font-size: 18px;
        font-weight: normal;
        vertical-align: top;
      }
      .ui-mini .ui-btn-inner {
        display: inline;
        padding: 2px;
      }
      a.ref {
        padding: 0px;
        margin: 0px;
        white-space: normal;
        display: inline;
      }
      a.definition.ui-link {
        border-bottom: 2px solid #666;
        background-color: #Fcd;
        text-decoration: none;
        color: #000 !important;
        font-weight: normal !important;
        padding: 1px;
        margin: 0px;
        padding-left: 3px;
        padding-right: 3px;
        border-radius: 5px;
      }
      a.definition.ui-link:hover {
        background-color: #FFF;
      }
      a.reference.ui-link {
        border-left: 2px solid #000;
        border-right: 2px solid #000;
        border-bottom: 1px solid #aaa;
        text-decoration: none;
        background-color: #cdf;
        color: #000 !important;
        font-weight: normal !important;
        padding: 0px;
        margin: 0px;
        padding-left: 5px;
        padding-right: 5px;
        border-radius: 8px;
      }
      a.reference.ui-link:hover {
        background-color: #FFF;
      }
      #evaluation {
        position: relative;
        z-index: 999;
        bottom: 0px;
        background-color: #ddf;
        padding: 4px;
        padding-top: 1px;
        padding-bottom: 15px;
        border-bottom: 1px solid #fff;
        font-family: arial, sans serif;
        display: none;
        border-radius: 5px;
      }
      #evaluation a {
        border: 1px solid #fff;
        text-decoration: none;
        text-align: center;
        font-weight: bold;
        padding: 5px;
        border-radius: 5px;
        background-color: #0A0;
        color: #FFF;
        text-shadow: 0px 1px #555;
      }
      /* bottom button */
      #evaluationButton {
        padding: 10px;
        background: #2b2;
        color: #fff;
        font-weight: bold;
        text-shadow: 0px 1px #555;
        text-decoration: none;
        border-radius: 25px;
        border: 1px solid #777;
      }
      #evaluationButton:hover {
        background: #2c2;
      }
      /* Adjust overall text size */
      p {
        font-size: 18px;
        line-height: 1.6em;
      }
      li {
        font-size: 18px;
      }
      #termsofuse p {
        font-size: 16px;
      }
      /* Add extra spacing between list items */
      .plainlist li {
        padding-top: 5px;
        padding-bottom: 5px;
      }
      /* style image used in quiz */
      .feedbackimage {
        width: 100%;
        max-width: 300px;
        margin: 0 auto;
        display: block;
      }
      /* Enlarge search box and make placeholder more legible */
      input.ui-input-text,
      textarea.ui-input-text {
        font-size: 18px;
        opacity: 1;
      }
      input::-webkit-input-placeholder {
        /* WebKit browsers */
        color: #333;
        opacity: 1;
      }
      input:-moz-placeholder {
        /* Mozilla Firefox 4 to 18 */
        color: #333;
        opacity: 1;
      }
      input::-moz-placeholder {
        /* Mozilla Firefox 19+ */
        color: #333;
        opacity: 1;
      }
      input:-ms-input-placeholder {
        /* Internet Explorer 10+ */
        color: #333;
        opacity: 1;
      }
      /* Remove search box background */
      form {
        background: none !important;
        border: none !important;
        margin-bottom: 30px !important;
      }
      .ui-input-search {
        background: #fff;
      }
      /*]]>*/
    </style>
    <!-- Google Analytics -->
    <script>
      (function(i, s, o, g, r, a, m) {
        i['GoogleAnalyticsObject'] = r;
        i[r] = i[r] || function() {
          (i[r].q = i[r].q || []).push(arguments)
        }, i[r].l = 1 * new Date();
        a = s.createElement(o),
        m = s.getElementsByTagName(o)[0];
        a.async = 1;
        a.src = g;
        m.parentNode.insertBefore(a, m)
      })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
      var sessionID = "0";
      ga('create', 'UA-44958852-1', 'optimalblooduse.eu');
      ga(function(tracker) {
        sessionID = tracker.get('clientId');
        ga('set', 'dimension1', sessionID);
      });
      ga('send', 'pageview');
    </script>
    <!-- End Google Analytics -->
    <script type="text/javascript">
      //<![CDATA[
      /* Begin data */
       // BCSH indications
      /*
    Data fields and their uses:

    title = Used as heading.
    key = Used to refer to entry, no displayed.
    definition = Used to explain title keywords, include reference.
    type = Overall recommendation, one of the following:
    -irradiated-cmv
    -irradiated
    -cmv
    -normal (special component not required)
    tags = used for indications search. Otherwise not visible.
    category = Used to group in indications list.
    checklist = Used to group for checklist.
    recommendation = Object holding guidelines and source:
    -type = the kind of indication the text relates to
    -text = a summary of the recommendation
    -verbatim = quote from the guidelines.
    -reference = id of source (see reference page for id)

    */
      var components = {
        "entries": [{
          "title": "Blood from a relative of the patient",
          "key": "relative",
          "definition": "",
          "type": "irradiated",
          "category": "component",
          "checklist": "",
          "tags": "blood component, directed donation, maternal blood, graft versus host disease, gvhd, ta-gvhd, family, mother, father, child, blood relation",
          "recommendation": [{
            "type": "irradiated",
            "verbatim": "All transfusions from <a href=\"javascript: showWord('relatives')\" class=\"definition\">first- or second-degree relatives</a> should be irradiated, even if the patient is immunocompetent (1B).",
            "reference": "bcsh2010"
          }]
        }, {
          "title": "Granulocytes",
          "key": "granulocytes",
          "definition": "\"Some clinicians believe that some patients with very low neutrophil counts and intractable sepsis can benefit from infusion of granulocyte concentrates. These may be prepared either by apheresis collections or derived from whole blood. [...] Clinical trials have not so far established effectiveness of the treatment\" <a href=\"javascript:showSource('htm2007')\" class=\"reference\">HTM 2007, p. 12<\/a>.",
          "type": "irradiated-cmv",
          "category": "component",
          "tags": "leukocytes, leucocytes, white cells, leucopenia, leukopenia, leukocytopenia, leucocytopenia, neutrophil, neutropaenia, neutropoenia, neutropenia, granolucyte, graft versus host disease, gvhd, ta-gvhd, cmv, cytomegalovirus, blood component",
          "recommendation": [{
            "type": "irradiated",
            "verbatim": "All granulocyte transfusions should be irradiated for recipients of any age, and they should be transfused  soon as possible after irradiation. (1C).",
            "reference": "bcsh2010"
          }, {
            "type": "irradiated",
            "verbatim": "As granulocytes cannot be <a href=\"javascript: showWord('leucodepletion')\" class=\"definition\">leucodepleted<\/a> and is usually given to immunocompromised patients, it is essential that the product be irradiated prior to transfusion to avoid graft-versus-host disease.",
            "reference": "ukbts2012"
          }, {
            "type": "cmv",
            "verbatim": "Granulocyte components should continue to be provided as CMV seronegative for CMV seronegative patients.",
            "reference": "sabto2012"
          }, {
            "type": "cmv",
            "verbatim": "CMV PCR monitoring should be considered for all patients (even CMV negative/negative patients) to allow early detection of any possible CMV infection (whether transfusion-transmitted or otherwise acquired).",
            "reference": "sabto2012"
          }]
        }, {
          "title": "Human Leucocyte Antigen (HLA)-selected components",
          "key": "hla",
          "type": "irradiated",
          "category": "component",
          "tags": "refractory, hla-matched, antigen, hla-compatible, homozygous, hla-selected, haplotype, genetic, chromosome, graft versus host disease, gvhd, ta-gvhd, blood component",
          "recommendation": [{
            "type": "irradiated",
            "verbatim": "All human leucocyte antigen (HLA)-selected components should be irradiated, even if the patient is immunocompetent (2C).",
            "reference": "bcsh2010"
          }]
        }, {
          "title": "Fresh frozen plasma, cryoprecipitate or plasma derivative",
          "key": "plasma",
          "definition": "\"Blood is a raw material from which different therapeutic products are made. These are blood components (red cell concentrates, platelet concentrates, fresh plasma and cryoprecipitate) and plasma derivatives (albumin, coagulation factors and immunoglobulins)\" <a href=\"javascript:showSource('htm2007')\" class=\"reference\">HTM 2007, p. 5<\/a>.",
          "type": "normal",
          "category": "component",
          "tags": "ffp, cryoprecipitate, fresh frozen plasma, non-cellular component, fractionated plasma, immunoglobulin, albumin, coagulation factors, clotting factors, fresh plasma, blood plasma, blood component",
          "recommendation": [{
            "type": "irradiated",
            "text": "It is not necessary to irradiate fresh frozen plasma, cryoprecipitate or fractionated plasma.",
            "verbatim": "For at-risk patients, all red cell, platelet and granulocyte components should be irradiated, except cryopreserved red cells after deglycerolization. It is not necessary to irradiate fresh frozen plasma, cryoprecipitate or fractionated plasma. (1B).",
            "reference": "bcsh2010"
          }, {
            "type": "cmv",
            "text": "CMV infection is associated with cellular blood components, such as red cells, tplatelets and granulocytes. Non-cellular components, such as fresh frozen plasma, cryoprecipitate and other plasma-derived blood components, do not need to be provided as CMV negative.",
            "verbatim": "Cell-associated viruses such as CMV and HTLV do not pose a risk to plasma-derived products.",
            "reference": "htm2007"
          }]
        }, {
          "title": "Red cells or platelets",
          "key": "redcellsplatelets",
          "definition": "\"Red cell transfusion is indicated to increase the oxygen delivering capacity of the blood when acute or chronic anaemia contributes to inadequate oxygen delivery to tissues\" <a href=\"javascript:showSource('htm2007')\" class=\"reference\">HTM 2007, p.7<\/a>. \"Platelet transfusions are indicated for the prevention and treatment of haemorrhage in patients with thrombocytopenia or platelet function defects\" <a href=\"javascript:showSource('htm2007')\" class=\"reference\">HTM 2007, p.8<\/a>.",
          "type": "maybe",
          "category": "component",
          "tags": "haemoglobin, platelets, anaemia, anemia, thrombocytopenia, haemorrhage, bleeding, blood component, cryopreserved red cells after deglycerolizationm red cells",
          "recommendation": [{
            "type": "irradiated",
            "text": "Red cells and platelets contain lymphocytes (white cells) that can cause transfusion-associated Graft versus Host Disease (TA-GvHD). Cryopreserved red cells after deglycerolization do not require irradiation because they are washed free of leucocytes. Irradiated platelets and red cells are only indicated for at-risk patients. Please consult <a href=\"#list\" class=\"definition\">the list of indications</a>.",
            "verbatim": " For at-risk patients, all red cell, platelet and granulocyte components should be irradiated, except cryopreserved red cells after deglycerolization. It is not necessary to irradiate fresh frozen plasma, cryoprecipitate or fractionated plasma. (1B).",
            "reference": "bcsh2010"
          }, {
            "type": "cmv",
            "verbatim": " CMV seronegative red cell and platelet components should be provided for intra-uterine transfusions and for neonates (ie up to 28 days post expected date of delivery), and therefore all small sized blood packs and other cellular blood components intended for neonates should be provided as CMV seronegative.",
            "reference": "sabto2012"
          }, {
            "type": "cmv",
            "verbatim": "CMV seronegative red cell and platelet components should be provided for elective transfusions during pregnancy (not during delivery) regardless of maternal CMV serostatus.",
            "reference": "sabto2012"
          }, {
            "type": "cmv",
            "verbatim": "If, in an emergency situation, it is not possible to provide CMV negative blood products, leucodepleted products of unknown serostatus may be used.",
            "reference": "sabto2012"
          }, {
            "type": "cmv",
            "verbatim": " All blood components (other than granulocytes) in the UK now undergo leucodepletion, which provides a significant degree of CMV risk reduction. This measure is considered adequate risk reduction for all other patients requiring transfusion (haemopoetic stem cell transplant patients, organ transplant patients, and immune deficient patients, including those with HIV) without the requirement for CMV seronegative components in addition.",
            "reference": "sabto2012"
          }, {
            "type": "cmv",
            "verbatim": "CMV PCR monitoring should be considered for all patients (even CMV negative/negative patients) to allow early detection of any possible CMV infection (whether transfusion-transmitted or otherwise acquired).",
            "reference": "sabto2012"
          }]
        }, {
          "title": "Purine analogue drugs",
          "key": "purineanalogues",
          "definition": "Purine analogues includes drugs such as fludarabine, cladribine, bendamustine, clofarabine, deoxycoformycin, thioguanine, pentastatin and cladribine. This list is not exhaustive and may change as new drugs become available.",
          "type": "irradiated",
          "category": "drug",
          "tags": "chemotherapy, fludarabine, cladribine, deoxycoformycin, thioguanine, pentastatin and cladribine, drug, immunosuppressive, immune system, immunocompromised, immunodeficiency, immunodeficient, alemtuzumab, campath, anti-cd52, graft versus host disease, gvhd, ta-gvhd, cancer",
          "recommendation": [{
            "type": "irradiated",
            "text": "Patients treated with purine analogue drugs (fludarabine, cladribine and deoxycoformicin) and purine antagonists (such as bendamustine and clofarabine) should receive irradiated blood components indefinitely. Recommendations may change as new drugs become available. See also entries for Alemtuzumab (Campath) and anti-thymocyte globulin (ATG)",
            "verbatim": "Patients treated with purine analogue drugs (fludarabine, cladribine and deoxycoformicin) should receive irradiated blood components indefinitely (1B). The situation with other purine antagonists and new and related agents, such as bendamustine and clofarabine, is unclear, but use of irradiated blood components is recommended as these agents have a similar mode of action. Irradiated blood components should be used after alemtuzumab (anti-CD52) therapy. Their use after rituximab (anti-CD20) is not recommended at this time. As new potent immunosupressive drugs and biological agents are introduced into practice there is a need for regular review of these recommendations (2C).",
            "reference": "bcsh2010"
          }]
        }, {
          "title": "Campath (Alemtuzumab)",
          "key": "campath",
          "type": "irradiated",
          "category": "drug",
          "tags": "drug, immunosuppressive, immune system, immunocompromised, immunodeficiency, immunodeficient, alemtuzumab, campath, anti-cd52, graft versus host disease, gvhd, ta-gvhd, cancer",
          "recommendation": [{
            "type": "irradiated",
            "text": "Patients treated with Alemtuzumab (anti-CD52 or Campath) should receive irradiated blood components.",
            "verbatim": "Patients treated with purine analogue drugs (fludarabine, cladribine and deoxycoformicin) should receive irradiated blood components indefinitely (1B). The situation with other purine antagonists and new and related agents, such as bendamustine and clofarabine, is unclear, but use of irradiated blood components is recommended as these agents have a similar mode of action. Irradiated blood components should be used after alemtuzumab (anti-CD52) therapy. Their use after rituximab (anti-CD20) is not recommended at this time. As new potent immunosupressive drugs and biological agents are introduced into practice there is a need for regular review of these recommendations (2C).",
            "reference": "bcsh2010"
          }]
        }, {
          "title": "Anti-thymocyte globulin (ATG)",
          "key": "atg",
          "type": "irradiated",
          "category": "drug",
          "tags": "drug, immunosuppressive, immune system, immunocompromised, immunodeficiency, immunodeficient, graft versus host disease, gvhd, ta-gvhd, cancer, Anti-thymocyte globulin, ATG, horse, rabbit",
          "recommendation": [{
            "type": "irradiated",
            "verbatim": "In view of the recent switch from horse anti-thymocyte globulin (ATG) to the more immunosuppressive rabbit ATG, we now recommend use of irradiated blood components for aplastic anaemia patients receiving immunosuppressive therapy with ATG (and/or alemtuzumab) (2C). We cannot make a firm recommendation as to how long irradiated components should continue to be used after ATG administration.",
            "reference": "bcsh2010"
          }]
        }, {
          "title": "Hodgkin lymphoma",
          "definition": "\"A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and reed-sternberg cells are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen\" <a href=\"javascript:showSource('mesh2013')\" class=\"reference\">MESH 2013<\/a>.",
          "key": "hodgin",
          "type": "irradiated",
          "category": "condition",
          "tags": "Hodgkin, hodkin, Hodgekin lymphoma, Hodgekin disease, current or history of medical condition, immunosuppressive, immune system, immunocompromised, immunodeficiency, immunodeficient, graft versus host disease, gvhd, ta-gvhd, cancer",
          "recommendation": [{
            "type": "irradiated",
            "verbatim": "All adults and children with Hodgkin lymphoma at any stage of the disease should have irradiated red cells and platelets for life (1B).",
            "reference": "bcsh2010"
          }]
        }, {
          "title": "Severe T lymphocyte immunodeficiency",
          "definition": "There are a long list of rare primary congenital or secondary acquired immunodeficiencies which may be an indication for irradiation: SCID, Di George syndrome, Wiskott Aldrich syndrome, reticular dysgnesis, ADA deficiency, chronic mucosal candidiasis, MHC class 1 or 2 deficiency. Seek expert immunologist advice.",
          "key": "immunodeficiency",
          "type": "irradiated",
          "category": "condition",
          "tags": "congenital, hereditary, cell-mediated, SCID, severe combined immunodeficiency, DiGeorge, Di George syndrome, Wiskott Aldrich syndrome, reticular dysgnesis, ADA deficiency, chronic mucosal candidiasis, MHC class 1 or 2 deficiency, current or history of medical condition, immunosuppressive, immune system, immunocompromised, immunodeficiency, immunodeficient, graft versus host disease, gvhd, ta-gvhd",
          "recommendation": [{
            "type": "irradiated",
            "verbatim": "All severe T lymphocyte immunodeficiency syndromes should be considered as indications for irradiation of cellular blood components.",
            "reference": "bcsh2010"
          }, {
            "type": "irradiated",
            "verbatim": "Once a diagnosis of immunodeficiency has been suspected, irradiated components should be given while further diagnostic tests are being undertaken.",
            "reference": "bcsh2010"
          }, {
            "type": "irradiated",
            "verbatim": "A clinical immunologist should be consulted for advice in cases where there is uncertainty (1A).",
            "reference": "bcsh2010"
          }, {
            "text": "Leucodepletion is considered adequate CMV risk reduction for immunodeficient patients and there is no requirement for CMV negative components in addition.",
            "verbatim": "No relevant literature was found that supported the use of CMV seronegative blood for immunodeficient patients. These patients should receive leucodepleted blood. All blood components (other than granulocytes) in the UK now undergo leucodepletion, which provides a significant degree of CMV risk reduction. This measure is considered adequate risk reduction for all other patients requiring transfusion (haemopoetic stem cell transplant patients, organ transplant patients, and immune deficient patients, including those with HIV) without the requirement for CMV seronegative components in addition.",
            "reference": "sabto2012"
          }, {
            "type": "cmv",
            "text": "Polymerase chain reaction (PCR) monitoring should be considered to detect signs of CMV infection early.",
            "verbatim": "CMV PCR monitoring should be considered for all patients (even CMV negative/negative patients) to allow early detection of any possible CMV infection (whether transfusion-transmitted or otherwise acquired).",
            "reference": "sabto2012"
          }]
        }, {
          "title": "Aplastic anaemia receiving ATG or Campath",
          "defintion": "A form of anemia in which the bone marrow fails to produce adequate numbers of peripheral blood elements <a href=\"javascript:showSource('mesh2013')\" class=\"reference\">MESH 2013<\/a>.",
          "key": "aplastic",
          "type": "irradiated",
          "category": "condition",
          "tags": "aplastic anaemia, anemia, current or history of medical condition, immunosuppressive, immune system, immunocompromised, immunodeficiency, immunodeficient, graft versus host disease, gvhd, ta-gvhd, haemoglobinopathy",
          "recommendation": [{
            "type": "irradiated",
            "text": "Use of irradiated blood components is recommended for aplastic anaemia patients receiving immunosuppressive therapy with anti-thymocyte globulin (ATG) or Campath (alemtuzumab).",
            "verbatim": "In view of the recent switch from horse anti-thymocyte globulin (ATG) to the more immunosuppressive rabbit ATG, we now recommend use of irradiated blood components for aplastic anaemia patients receiving immunosuppressive therapy with ATG (and/or alemtuzumab) (2C). We cannot make a firm recommendation as to how long irradiated components should continue to be used after ATG administration.",
            "reference": "bcsh2010"
          }]
        }, {
          "title": "HIV, AIDS or other common viral infection",
          "key": "hiv",
          "type": "normal",
          "category": "condition",
          "tags": "aids, hiv, virus, current or history of medical condition, immunosuppressive, immune system, immunocompromised, immunodeficiency, immunodeficient, graft versus host disease, gvhd, ta-gvhd",
          "recommendation": [{
            "type": "irradiated",
            "text": "Irradiated components are not indicated for common viral infections, HIV or AIDS.",
            "verbatim": "There is no indication for routine irradiation of cellular blood components for infants or children who are suffering from a common viral infection, who are human immunodeficiency virus (HIV) antibody positive, or who have acquired immunodeficiency syndrome (AIDS). However, this should be kept under review. There is also no indication for routine irradiation of cellular blood components for adults who are HIV antibody positive or who have AIDS (2B).",
            "reference": "bcsh2010"
          }, {
            "type": "cmv",
            "text": "Leucodepletion is considered adequate CMV risk reduction for patients with HIV or AIDS and there is no requirement for CMV negative blood components in addition.",
            "verbatim": "All blood components (other than granulocytes) in the UK now undergo leucodepletion, which provides a significant degree of CMV risk reduction. This measure is considered adequate risk reduction for all other patients requiring transfusion (haemopoetic stem cell transplant patients, organ transplant patients, and immune deficient patients, including those with HIV) without the requirement for CMV seronegative components in addition.",
            "reference": "sabto2012"
          }, {
            "type": "cmv",
            "text": "Polymerase chain reaction (PCR) monitoring should be considered to detect signs of CMV infection early.",
            "verbatim": "CMV PCR monitoring should be considered for all patients (even CMV negative/negative patients) to allow early detection of any possible CMV infection (whether transfusion-transmitted or otherwise acquired).",
            "reference": "sabto2012"
          }]
        }, {
          "title": "Leukaemia",
          "id": "leukaemia",
          "definition": "\"A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells\" <a href=\"javascript:showSource('mesh2013')\" class=\"reference\">MESH 2013<\/a>.",
          "type": "normal",
          "category": "condition",
          "tags": "leukaemia, leucaemia, leucemia, leukemia, current or history of medical condition, immunosuppressive, immune system, immunocompromised, immunodeficiency, immunodeficient, graft versus host disease, gvhd, ta-gvhd, cancer, malignancy, malignant, leukocyte, leucocyte",
          "recommendation": [{
            "type": "irradiated",
            "verbatim": "It is not necessary to irradiate red cells or platelets for adults or children with acute leukaemia, except for HLA-selected platelets or donations from <a href=\"javascript: showGlossary('relatives')\" class=\"glossary\">first- or second-degree relatives</a> (1B).",
            "reference": "bcsh2010"
          }, {
            "type": "cmv",
            "verbatim": "Patients requiring transfusions who may require a transplant in the future may also safely be transfused with leucodepleted products (eg seronegative leukaemia or thalassaemia patients).",
            "reference": "sabto2012"
          }, {
            "type": "cmv",
            "text": "Polymerase chain reaction (PCR) monitoring should be considered to detect signs of CMV infection early.",
            "verbatim": "CMV PCR monitoring should be considered for all patients (even CMV negative/negative patients) to allow early detection of any possible CMV infection (whether transfusion-transmitted or otherwise acquired).",
            "reference": "sabto2012"
          }]
        }, {
          "title": "Transfusions during pregnancy",
          "key": "pregnancy",
          "type": "cmv",
          "category": "neonatology",
          "tags": "neonatal, neonatology, obstetrics, pregnancy, fetus, neonate, fetal, infant, birth, delivery, intrauterine transfusion, exchange transfusion, uterine, cmv, cytomegalovirus, mother, maternal",
          "recommendation": [{
            "type": "cmv",
            "verbatim": "CMV seronegative red cell and platelet components should be provided for elective transfusions during pregnancy (not during delivery) regardless of maternal CMV serostatus.",
            "reference": "sabto2012"
          }, {
            "type": "cmv",
            "verbatim": "If, in an emergency situation, it is not possible to provide CMV negative blood products, leucodepleted products of unknown serostatus may be used.",
            "reference": "sabto2012"
          }]
        }, {
          "title": "Neonatal alloimmune thrombocytopenia",
          "id": "neonate",
          "definition": "\"A condition in newborns caused by immunity of the mother to platelet alloantigens on the fetal platelets. The platelets, coated with maternal antibodies, are destroyed and removed by the fetal mononuclear phagocyte system. Affected infants may have intracranial haemorrhages\" <a href=\"javascript:showSource('mesh2013')\" class=\"reference\">MESH 2013<\/a>.",
          "type": "irradiated-cmv",
          "category": "neonatology",
          "tags": "current or history of medical condition, immunosuppressive, immune system, immunocompromised, immunodeficiency, immunodeficient, graft versus host disease, gvhd, ta-gvhd, neonatal, neonatology, obstetrics, alloimmune thrombocytopenia, newborn, platelets, fetal, infants, haemorrhage, baby, NAIP",
          "recommendation": [{
            "type": "irradiated",
            "verbatim": "Platelets transfused in utero to treat alloimmune thrombocytopenia should be irradiated and any subsequent red cell or platelet transfusions irradiated until 6 months after the expected date of delivery (40 weeks gestation). ",
            "reference": "bcsh2010"
          }, {
            "type": "irradiated",
            "verbatim": "For intrauterine transfusion (IUT) and exchange transfusion (ET), blood should be transfused within 24 h of irradiation and, in any case, by 5 days or less from collection (1A).",
            "reference": "bcsh2010"
          }, {
            "type": "irradiated",
            "text": "There is no need to irradiate platelets for pre-term or term infants, unless it has been donated by relatives or newborn has had previous in utero transfusion.",
            "verbatim": "There is no need to irradiate other platelet transfusions for pre-term or term infants, unless they have been donated by <a href=\"javascript: showGlossary('relatives')\" class=\"glossary\">first- or second-degree relatives</a> (1C).",
            "reference": "bcsh2010"
          }, {
            "type": "cmv",
            "text": "CMV negative blood components should be provided for neonates.",
            "verbatim": "CMV seronegative red cell and platelet components should be provided for intra-uterine transfusions and for neonates (ie up to 28 days post expected date of delivery), and therefore all small sized blood packs and other cellular blood components intended for neonates should be provided as CMV seronegative.",
            "reference": "sabto2012"
          }]
        }, {
          "title": "Intrauterine transfusions (IUT)",
          "definition": "\"In utero transfusion of blood into the fetus for the treatment of fetal diseases, such as fetal erythroblastosis\" <a href=\"javascript:showSource('mesh2013')\" class=\"reference\">MESH 2013<\/a>.",
          "key": "iut",
          "type": "irradiated-cmv",
          "category": "neonatology",
          "tags": "HDN, haemolytic disease of the newborn, NAITP , neonatal alloimmune thrombocytopenia, neonatal, neonatology, obstetrics, pregnancy, fetus, neonate, fetal, infant, birth, delivery, in utero, intra uterine, intra-uterine, intrauterine transfusion, exchange transfusion, uterine, immunosuppressive, immune system, immunocompromised, immunodeficiency, immunodeficient, graft versus host disease, gvhd, ta-gvhd, cmv, cytomegalovirus, infection",
          "recommendation": [{
            "type": "irradiated",
            "verbatim": "All blood for intrauterine transfusion (IUT) should be irradiated (1B).",
            "reference": "bcsh2010"
          }, {
            "type": "irradiated",
            "verbatim": "For IUT and exchange transfusion (ET), blood should be transfused within 24 h of irradiation and, in any case, by 5 days or less from collection (1A).",
            "reference": "bcsh2010"
          }, {
            "type": "cmv",
            "text": "CMV negative blood components should be provided for intrauterine transfusions.",
            "verbatim": "CMV seronegative red cell and platelet components should be provided for intra-uterine transfusions and for neonates (ie up to 28 days post expected date of delivery), and therefore all small sized blood packs and other cellular blood components intended for neonates should be provided as CMV seronegative.",
            "reference": "sabto2012"
          }]
        }, {
          "title": "Neonatal exchange transfusions",
          "key": "exchange",
          "definition": "\"Repetitive withdrawal of small amounts of blood and replacement with donor blood until a large proportion of the blood volume has been exchanged\" <a href=\"javascript:showSource('mesh2013')\" class=\"reference\">MESH 2013<\/a>.",
          "type": "irradiated-cmv",
          "category": "neonatology",
          "tags": "neonatal, neonatology, obstetrics, pregnancy, neonate, infant, birth, delivery, exchange transfusion, immunosuppressive, immune system, immunocompromised, immunodeficiency, immunodeficient, graft versus host disease, gvhd, ta-gvhd, cmv, cytomegalovirus, infection",
          "recommendation": [{
            "type": "irradiated",
            "verbatim": "Blood for neonatal exchange transfusion (ET) must be irradiated if there has been a previous intrauterine transfusion (IUT) or if the donation comes from a first- or second-degree relative. (1B)",
            "reference": "bcsh2010"
          }, {
            "type": "irradiated",
            "verbatim": "For other neonatal ET cases, irradiation is recommended provided this does not unduly delay transfusion (1C).",
            "reference": "bcsh2010"
          }, {
            "type": "irradiated",
            "verbatim": "For intrauterine transfusion (IUT) and ET, blood should be transfused within 24 h of irradiation and, in any case, by 5 days or less from collection (1A).",
            "reference": "bcsh2010"
          }, {
            "type": "cmv",
            "text": "CMV negative blood components should be provided for neonates.",
            "verbatim": "CMV seronegative red cell and platelet components should be provided for intra-uterine transfusions and for neonates (ie up to 28 days post expected date of delivery), and therefore all small sized blood packs and other cellular blood components intended for neonates should be provided as CMV seronegative.",
            "reference": "sabto2012"
          }]
        }, {
          "title": "Routine infant 'top-up'",
          "definition": "An infant is defined as a child between 1 and 23 months of age <a href=\"javascript:showSource('mesh2013')\" class=\"reference\">MESH 2013<\/a>.",
          "key": "top-up",
          "type": "maybe",
          "category": "neonatology",
          "tags": "infant, neonatology, top up, transfusion, routine",
          "recommendation": [{
            "type": "irradiated",
            "verbatim": "It is not necessary to irradiate red cells for routine 'top-up' transfusions of premature or term infants unless either there has been a previous intrauterine transfusion (IUT), in which case irradiated components should be administered until 6 months after the expected delivery date (40 weeks gestation), or the donation has come from a first- or second-degree relative (2C).",
            "reference": "bcsh2010"
          }]
        }, {
          "title": "Infant cardiac surgery",
          "key": "surgery",
          "definition": "An infant is defined as a child between 1 and 23 months of age <a href=\"javascript:showSource('mesh2013')\" class=\"reference\">MESH 2013<\/a>.",
          "type": "maybe",
          "category": "neonatology",
          "tags": "cardiac, heart, operation, surgery, obstetrics, paediatrics, pediatrics, neonatology, infant",
          "recommendation": [{
            "type": "irradiated",
            "verbatim": "There is no need to irradiate red cells or platelets for infants undergoing cardiac surgery unless clinical or laboratory features suggest a coexisting T lymphocyte immunodeficiency syndrome (2B).",
            "reference": "bcsh2010"
          }]
        }, {
          "title": "Allogeneic haemopoietic stem cell transplant recipients",
          "definition": "Recipient of stem cells donated by a genetically non-identical donor.",
          "key": "stemcell",
          "type": "irradiated",
          "category": "transplant",
          "tags": "HSC, stem cells, transplant, allogeneic, haemopoietic, oncology, immunosuppressive, immune system, immunocompromised, immunodeficiency, immunodeficient, graft versus host disease, gvhd, ta-gvhd, chemoradiotherapy",
          "recommendation": [{
            "type": "irradiated",
            "verbatim": "All recipients of allogeneic haemopoietic stem cell transplantation (HSCT) must receive irradiated blood components from the time of initiation of conditioning chemoradiotherapy (1B).",
            "reference": "bcsh2010"
          }, {
            "type": "irradiated",
            "verbatim": "This should be continued while the patient continues to receive graft-versus-host disease (GvHD) prophylaxis, i.e. usually for 6 months post-transplant, or until lymphocytes are > 1 x 10^9/l. If chronic GvHD is present or if continued immunosuppressive treatment is required, irradiated blood components should be given indefinitely (2C).",
            "reference": "bcsh2010"
          }, {
            "type": "irradiated",
            "verbatim": "Allogeneic blood transfused to bone marrow and peripheral blood stem cell donors 7 days prior to or during the harvest should also be irradiated (2C).",
            "reference": "bcsh2010"
          }, {
            "type": "cmv",
            "text": "Leucodepletion provides adequate risk reduction for patients undergoing haemopoietic stem cell transplant.",
            "verbatim": "CMV seronegative red cells and platelets may be replaced with leucodepleted blood components for adults and children post haemopoeitic stem cell transplantation, for all patient groups including seronegative donor/seronegative recipients.",
            "reference": "sabto2012"
          }, {
            "type": "cmv",
            "text": "Polymerase chain reaction (PCR) monitoring should be considered to detect signs of CMV infection early.",
            "verbatim": "CMV PCR monitoring should be considered for all patients (even CMV negative/negative patients) to allow early detection of any possible CMV infection (whether transfusion-transmitted or otherwise acquired).",
            "reference": "sabto2012"
          }, {
            "type": "cmv",
            "text": "Patients who may require a transplant in the future do not require CMV seronegative blood.",
            "verbatim": "Patients requiring transfusions who may require a transplant in the future may also safely be transfused with leucodepleted products (eg seronegative leukaemia or thalassaemia patients).",
            "reference": "sabto2012"
          }]
        }, {
          "title": "Autologous bone marrow or stem cell harvest",
          "defintion": "In autologous stem cell transplantation stem cells are removed, stored, and later given back to the same person.",
          "key": "harvest",
          "type": "irradiated",
          "category": "transplant",
          "tags": "Autologous, harvest, transplant, stem cell, bone marrow, PBSC, GvHD, graft versus host disease, peripheral blood stem cell",
          "recommendation": [{
            "type": "irradiated",
            "verbatim": "Patients undergoing bone marrow or peripheral blood stem cell harvesting for future autologous re-infusion should receive irradiated cellular blood components during and for 7 days before the bone marrow/stem cell harvest to prevent the collection of viable allogeneic T lymphocytes which can potentially withstand cryopreservation (2C).",
            "reference": "bcsh2010"
          }]
        }, {
          "title": "Autologous bone marrow or stem cell transplant",
          "defintion": "In autologous stem cell transplantation stem cells are removed, stored, and later given back to the same person.",
          "key": "transplant",
          "type": "irradiated",
          "category": "transplant",
          "tags": "Autologous, transplant, stem cell, bone marrow, PBSC, GvHD, graft versus host disease, peripheral blood stem cell",
          "recommendation": [{
            "type": "irradiated",
            "verbatim": "All patients undergoing autologous bone marrow transplant or peripheral blood stem cell transplant should receive irradiated cellular blood components from initiation of conditioning chemo/radiotherapy until 3 months post-transplant (6 months if total body irradiation was used in conditioning) (2C).",
            "reference": "bcsh2010"
          }, {
            "type": "cmv",
            "text": "Leucodepletion provides adequate risk reduction for patients undergoing haemopoietic stem cell transplant.",
            "verbatim": "CMV seronegative red cells and platelets may be replaced with leucodepleted blood components for adults and children post haemopoeitic stem cell transplantation, for all patient groups including seronegative donor/seronegative recipients.",
            "reference": "sabto2012"
          }, {
            "type": "cmv",
            "text": "Polymerase chain reaction (PCR) monitoring should be considered to detect signs of CMV infection early.",
            "verbatim": "CMV PCR monitoring should be considered for all patients (even CMV negative/negative patients) to allow early detection of any possible CMV infection (whether transfusion-transmitted or otherwise acquired).",
            "reference": "sabto2012"
          }, {
            "type": "cmv",
            "text": "Patients who may require a transplant in the future do not require CMV seronegative blood.",
            "verbatim": "Patients requiring transfusions who may require a transplant in the future may also safely be transfused with leucodepleted products (eg seronegative leukaemia or thalassaemia patients).",
            "reference": "sabto2012"
          }]
        }]
      };
      /* Begin settings and global vars */
       // Remove page transitions to speed up things
      $.mobile.defaultPageTransition = 'none';
       // Require longer and faster swipes
      $.event.special.swipe.horizontalDistanceThreshold = 30;
      $.event.special.swipe.durationThreshold = 300;
       // Store quiz performance
      var correctAnswers = 0;
      var attempts = 0;
       // Array for random quiz list
      var quizQuestions = components.entries.slice(0);
      /* Begin object overrides */
       // Randomise array ordering
      Array.prototype.shuffle = function() {
        var i = this.length,
          j, temp;
        if (i == 0) return this;
        while (--i) {
          j = Math.floor(Math.random() * (i + 1));
          temp = this[i];
          this[i] = this[j];
          this[j] = temp;
        }
        return this;
      }
      /* Begin event listeners */
      // Attempt to remove browser chrome in android
      /*
      window.addEventListener('load', function() {
          window.scrollTo(0, 1);
      }, false);
      */
       // record page change in analytics
      $(document).on("pagecreate", "[data-role='page']", function() {
        var page = "#" + $(this).attr("id");
        ga('send', 'pageview', '/app/' + page);
      });
       // Enable navigation by swiping left and right
       // Disable due to poor usability!
      /*
        $( document ).on("pagecreate", "[data-role='page']", function() {
                        var page = "#" + $( this ).attr( "id" ),
                                // Next page stored in the data-next attribute
                                next = $( this ).jqmData( "next" ),
    
                // Previous page stored in the data-prev attribute
                                prev = $( this ).jqmData( "prev" );
            
                if ( next ) {
                // Navigate to next page on swipe left
                                $( document ).on( "swipeleft", page, function() {
                                        $.mobile.changePage(next);
                                });
                        }
            
                if ( prev ) {
                // Navigate to next page on swipe left
                                $( document ).on( "swiperight", page, function() {
                                        $.mobile.changePage(prev);
                                });
                        }
                });
      */
      
      /* Expand and collapse references */
      $(document).on('click', '#expandReferences', function(e) {
        $('#referenceCollection .ui-collapsible.ui-collapsible-collapsed').attr('data-collapsed', false).removeClass("ui-collapsible-collapsed").find('.ui-collapsible-content').removeClass('ui-collapsible-content-collapsed');
        $('#referenceCollection .ui-collapsible .ui-icon').removeClass('ui-icon-plus').addClass('ui-icon-minus');
      });
      $(document).on('click', '#collapseReferences', function(e) {
        $('#referenceCollection div').trigger('collapse');
      });
      /* Expand and collapse glossary */
      $(document).on('click', '#expandGlossary', function(e) {
        $('#glossaryCollection .ui-collapsible.ui-collapsible-collapsed').attr('data-collapsed', false).removeClass("ui-collapsible-collapsed").find('.ui-collapsible-content').removeClass('ui-collapsible-content-collapsed');
        $('#glossaryCollection .ui-collapsible .ui-icon').removeClass('ui-icon-plus').addClass('ui-icon-minus');
      });
      $(document).on('click', '#collapseGlossary', function(e) {
        $('#glossaryCollection div').trigger('collapse');
      });
      /* Make quiz question */
      $("#quiz").on("pagecontainershow", function(event) {
        $('#quizRound').text('Question ' + (currentQuestion + 1) + ' of ' + (quizQuestions.length)) + " (" + Math.floor(correctAnswers / attempts) + "% correct)";
        var componentString = 'red cells or platelets';
        var articleText = (quizQuestions[currentQuestion].category.search('condition') > -1) ? componentString + " for patients with a current episode (or history) of" : componentString + " for";
        articleText = (quizQuestions[currentQuestion].category.search('component') > -1) ? "" : articleText;
        $('#quizArticle').text(articleText);
        // convert title to sentence case
        var questionString = quizQuestions[currentQuestion].title.substr(0, 1).toLowerCase() + quizQuestions[currentQuestion].title.substr(1);
        // unless starts with HIV
        if (quizQuestions[currentQuestion].title.substr(0, 1) == "H") {
          questionString = quizQuestions[currentQuestion].title;
        }
        questionString = (quizQuestions[currentQuestion].title.search('stem cell') > -1 && quizQuestions[currentQuestion].title.search('recipient') < 1) ? "patients undergoing " + questionString : questionString;
        questionString = (quizQuestions[currentQuestion].category.search('treatment') > -1 || quizQuestions[currentQuestion].category.search('drug') > -1) ? "patients who have been treated with " + questionString : questionString;
        questionString += (questionString.search(/transfusion/i) > -1) ? " be supplied?" : " be transfused?";
        $('#quizQuestion').text(questionString);
        var descriptionText = quizQuestions[currentQuestion].definition;
        var quizDef = "";
        if (descriptionText) {
          quizDef = '<div data-role="collapsible" data-collapsed="true" data-content-theme="b" data-theme="b"><h3>Details<\/h3><p>' + descriptionText + '<\/p><\/div>';
        }
        $('#quizDefinition').html(quizDef).trigger("create");
      });
       // Randomise quiz order on first page load
      $("#quiz").on("pagecreate", function(event) {
        startQuiz();
      });
       // Generate list of indications
      $("#list").on("pagecreate", function(event) {
        alert ("pc")
        generateIndications("all", "#allIndications");
        $('input[data-type="search"]').focus(function() {
          $('input[data-type="search"]').attr("placeholder", "");
        });
        $('input[data-type="search"]').blur(function() {
          $('input[data-type="search"]').attr("placeholder", "Enter keyword here");
        });
      });
      /* Begin function declarations */
       // Generate list of indications
      function generateSubset(keyword, referer) {
        $.mobile.changePage('#subset');
        generateIndications(keyword, "#subsetIndications", referer);
        $('#checklistInstructions').text('There are several relevant indications. Please select an item from the list to view details.');
        /*
        $('input[data-type="search"]').focus(function () {
            $('input[data-type="search"]').attr("placeholder", "");
        });

        $('input[data-type="search"]').blur(function () {
            $('input[data-type="search"]').attr("placeholder", "Enter keyword here");
        });
    */
      }
      /* navigate to reference page and scroll to ref */
      function showSource(elementId) {
        $.mobile.changePage('#references');
        $('#' + elementId).trigger('expand');
        $('html, body').animate({
          scrollTop: $('#' + elementId).offset().top
        });
      }
      /* navigate to glossary page and scroll to word */
      function showWord(elementId) {
        //alert($.mobile.activePage.attr('id'));
        $.mobile.changePage('#glossary');
        $('#' + elementId).trigger('expand');
        $('html, body').animate({
          scrollTop: $('#' + elementId).offset().top
        });
      }
       // Randomise quiz question order
      function startQuiz() {
        quizQuestions.shuffle();
        currentQuestion = 0;
        correctAnswers = 0;
        attempts = 0;
      }

      function answerQuiz(component) {
        if (component == "previous") {
          if (currentQuestion > 0) {
            currentQuestion--;
            jQuery('#quiz').trigger('pagecontainershow');
          }
          return;
        }
        if (component == "next") {
          if (currentQuestion + 1 < quizQuestions.length) {
            currentQuestion++;
            jQuery('#quiz').trigger('pagecontainershow');
          }
          return;
        }
        if (component == quizQuestions[currentQuestion].type) {
          showAnswer(true, component);
        } else {
          showAnswer(false, component);
        }
        currentQuestion++;
        if (currentQuestion >= quizQuestions.length) {
          startQuiz();
        }
      }
      /* Generate quiz answer text based */
      function showAnswer(correctAnswer, component) {
        attempts++;
        $("#quizTitle").html('');
        $("#quizRecommendation").html('');
        $("#quizCorrect").html('');
        if (correctAnswer) {
          $("#quizVerdict").html("Well done!");
        } else {
          $("#quizVerdict").html("Try again!");
        }
        $("#quizTitle").html(quizQuestions[currentQuestion].title);
        /*
        $('<h2><a onclick="return false;" href="javascript: return false;" data-role="button" data-iconpos="notext" data-inline="true" data-theme="b" data-icon="' + icons[quizQuestions[currentQuestion].type] + '">Nothing<\/a>' + buttonLabels[quizQuestions[currentQuestion].type] + '<\/h2><p>' + quizQuestions[currentQuestion].recommendation + '<\/p>' + readingLink).appendTo("#quizRecommendation");
    */
        switch (component) {
          case "irradiated-cmv":
            component = "irradiated and CMV negative";
            break;
          case "irradiated":
            component = "irradiated";
            break;
          case "cmv":
            component = "CMV negative";
            break;
          case "maybe":
            component = "not enough information";
            break;
          default:
            component = "special component not required";
            break;
        }
        var specialRequirement = '';
        switch (quizQuestions[currentQuestion].type) {
          case "irradiated-cmv":
            specialRequirement = "irradiated and CMV negative blood components";
            break;
          case "irradiated":
            specialRequirement = "irradiated blood components";
            break;
          case "cmv":
            specialRequirement = "CMV negative blood components";
            break;
          case "maybe":
            specialRequirement = "not enough information";
            break;
          default:
            specialRequirement = "neither irradiated nor CMV negative blood components";
            break;
        }
        if (correctAnswer && component == "not enough information") {
          var feedback = '<p>Transfusion of platelets and red cells alone is not an indication for irradiation or cmv negative. But these components can cause CMV infection and TA-GvHD if transfused to patients at risk.<\/p><img src="rightchar.png"  class="feedbackimage">';
          correctAnswers++;
        } else if (!correctAnswer && quizQuestions[currentQuestion].key == "redcellsplatelets") {
          var feedback = '<p>You incorrectly answered ' + component + '! Transfusion of platelets and red cells <i>alone<\/i> is not an indication for irradiation or cmv negative. Whilst these components can cause CMV infection and TA-GvHD, irradiated and cmv negative components are <i>only<\/i> indicated to patients at risk. The correct answer option is "not enough information".<\/p><img src="wrongchar.png" class="feedbackimage">';
        } else if (!correctAnswer && component == "not enough information") {
          var feedback = '<p>The guidelines recommend <b>' + specialRequirement + '<\/b>! However, you incorrectly answered "not enough information".<\/p><img src="wrongchar.png" class="feedbackimage"> ';
        } else if (correctAnswer) {
          var feedback = '<p>You prescribed <b> ' + specialRequirement + ' <\/b> according to the guidelines.<\/p><img src="rightchar.png" class="feedbackimage">';
          correctAnswers++;
        } else if (component == "special component not required") {
          var feedback = '<p>The guidelines recommend <b>' + specialRequirement + '<\/b>! However, you incorrectly answered "' + component + '"! <\/p><img src="wrongchar.png" class="feedbackimage">';
        } else {
          var feedback = '<p>The guidelines recommend <b>' + specialRequirement + '<\/b>! However, you incorrectly prescribed ' + component + '! <\/p><img src="wrongchar.png" class="feedbackimage">';
        }
        $("#quizRecommendation").trigger("create");
        $("#quizCorrect").html(feedback);
        $.mobile.changePage('#quizAnswer');
      }
      /* Display indication details.
       Used for main indications list.*/
      function showIndication(id, referer) {
        // if it is not a number, convert it to one
        if (isNaN(id)) {
          $.each(components.entries, function(i, item) {
            if (item.key == id) {
              id = i;
            }
          });
        }
        // Support back without history push state:
        referer = (referer) ? referer : "#list";
        $(".indicationBack").attr("href", referer);
        $("#indicationTitle").html('');
        $("#indicationTitle").html(components.entries[id].title);
        $("#irradiatedRecommendation").html('');
        $("#cmvRecommendation").html('');
        $("#overallRecommendation").html('');
        var cmvText = '';
        var irrText = '';
        var cmvShort = '';
        var irrShort = '';
        var cmvSource = '';
        var irrSource = '';
        var cmvCounter = 0
        var irrCounter = 0;
        // Loop through the recommendations for the entry
        for (var i = 0; i < components.entries[id].recommendation.length; i++) {
          // Check irradiated guidelines
          if (components.entries[id].recommendation[i].type == "irradiated") {
            irrCounter++;
            // Check if brief text available
            if (components.entries[id].recommendation[i].text) {
              irrText += '<li>' + components.entries[id].recommendation[i].text + '<\/li>';
              irrSource += '<li>"' + components.entries[id].recommendation[i].verbatim + '" <a href="javascript: showSource(' + "'" + components.entries[id].recommendation[i].reference + "'" + ')" class="reference">' + components.entries[id].recommendation[i].reference.toUpperCase() + '<\/a><\/li>';
            }
            // Otherwise use quote
            else {
              irrText += '<li>"' + components.entries[id].recommendation[i].verbatim + '" <a href="javascript: showSource(' + "'" + components.entries[id].recommendation[i].reference + "'" + ')" class="reference">' + components.entries[id].recommendation[i].reference.toUpperCase() + '<\/a><\/li>';
            }
          }
          // Repeat for cmv guidelines
          else {
            cmvCounter++;
            // Check if brief text available
            if (components.entries[id].recommendation[i].text) {
              cmvText += '<li>' + components.entries[id].recommendation[i].text + '<\/li>';
              cmvSource += '<li>"' + components.entries[id].recommendation[i].verbatim + '" <a href="javascript: showSource(' + "'" + components.entries[id].recommendation[i].reference + "'" + ')" class="reference">' + components.entries[id].recommendation[i].reference.toUpperCase() + '<\/a><\/li>';
            }
            // Otherwise use quote
            else {
              cmvText += '<li>"' + components.entries[id].recommendation[i].verbatim + '" <a href="javascript: showSource(' + "'" + components.entries[id].recommendation[i].reference + "'" + ')" class="reference">' + components.entries[id].recommendation[i].reference.toUpperCase() + '<\/a><\/li>';
            }
          }
        }
        var recommendation = components.entries[id].type;
        var recommendationHeading;
        var icon;
        var irrSymbol = "alert";
        var cmvSymbol = "alert";
        var irrTheme = "g";
        var cmvTheme = "g";
        var irrHeading = "Irradiation required.";
        var cmvHeading = "CMV negative required regardless of serostatus.";
        var recommendationTheme = "#FDD";
        switch (recommendation) {
          // todo
          case "irradiated-cmv":
            if (components.entries[id].title == "Granulocytes") {
              recommendationHeading = "Irradiation required.<br/>CMV negative required for CMV negative patients.";
              cmvHeading = 'CMV negative required for CMV negative patients.';
            } else recommendationHeading = "Irradiation required. <br/>CMV negative required regardless of serostatus.";
            icon = "red.png";
            break;
          case "irradiated":
            recommendationHeading = "Irradiation required.";
            icon = "red.png";
            cmvTheme = "h";
            cmvSymbol = "check";
            cmvHeading = "CMV negative not required";
            break;
          case "cmv":
            recommendationHeading = "CMV negative required regardless of serostatus.";
            icon = "red.png";
            irrTheme = "h";
            irrSymbol = "check";
            irrHeading = "Irradiation not required";
            break;
          case "maybe":
            recommendationHeading = "Irradiation may be required.<br/>CMV negative may be required.";
            icon = "yellow.png";
            irrTheme = "e";
            cmvTheme = "e";
            irrHeading = "Irradiation may be required!";
            cmvHeading = "CMV negative may be required!";
            recommendationTheme = "#FFD";
            break;
          case "normal":
            recommendationHeading = "Irradiation not required. <br/>CMV negative not required.";
            icon = "green.png";
            irrTheme = "h";
            cmvTheme = "h";
            irrSymbol = "check";
            cmvSymbol = "check";
            irrHeading = "Irradiation not required";
            cmvHeading = "CMV negative not required";
            recommendationTheme = "#DFD";
            break;
        }
        var headingHtml = '<div class="ui-grid-a" style="background: ' + recommendationTheme + '; border-radius: 10px; border: 1px solid #000;"><div class="ui-block-a custom" ><img src="' + icon + '" style="vertical-align: bottom; width:120px;" /><\/div><div class="ui-block-b custom"><h2 style="margin: 0px; margin-top: 0.1em; margin-bottom: 0.1em;  line-height: 1em;">' + recommendationHeading + '<\/h2><\/div><\/div><br/>';
        var irrHtml = '';
        var cmvHtml = '';
        var guidelinesHtml = '';
        if (irrCounter > 0) {
          irrHtml += '<div data-role="collapsible-set" style="margin: 0px;" data-theme="' + irrTheme + '" data-content-theme="' + irrTheme + '"><div data-role="collapsible" data-collapsed="false" data-expanded-icon="' + irrSymbol + '" data-collapsed-icon="' + irrSymbol + '"><h3>' + irrHeading + '<\/h3><ol class="plainlist"> ' + irrText + '<\/ol><\/div>';
          if (irrSource) {
            irrHtml += '<div data-role="collapsible"><h3>More details<\/h3><ol class="plainlist"> ' + irrSource + ' <\/ol><\/div>';
          }
          irrHtml += '<\/div><br/>';
        }
        if (cmvCounter > 0) {
          cmvHtml += '<div data-role="collapsible-set" style="margin: 0px;" data-theme="' + cmvTheme + '" data-content-theme="' + cmvTheme + '"><div  data-role="collapsible" data-collapsed="false" data-expanded-icon="' + cmvSymbol + '" data-collapsed-icon="' + cmvSymbol + '"><h3>' + cmvHeading + '<\/h3><ol class="plainlist"> ' + cmvText + '<\/ol><\/div>';
          if (cmvSource) {
            cmvHtml += '<div data-role="collapsible" data-collapsed="true"><h3>More details<\/h3><ol class="plainlist"> ' + cmvSource + ' <\/ol><\/div>';
          }
          cmvHtml += '<\/div><br/>';
        }
        // If we got irradiation guidelines, present these first
        if (recommendation == "cmv") {
          $("#overallRecommendation").html(headingHtml + cmvHtml + irrHtml).trigger("create");
        } else {
          $("#overallRecommendation").html(headingHtml + irrHtml + cmvHtml).trigger("create");
        }
        // Check if definition is available
        $("#pageDefinition").html('');
        $("#pageTags").html('');
        var definition = components.entries[id].definition;
        var tags = components.entries[id].tags;
        tags = ''; // hide tags
        definition = ''; // hide description
        if (definition && tags) {
          $("#pageDefinition").html('<div data-role="collapsible-set" data-content-theme="b" data-theme="b"><div data-role="collapsible"><h3>Entry description<\/h3><p>' + definition + ' <\/p><\/div><div data-role="collapsible"><h3>Entry keywords<\/h3><p>' + tags + '<\/p><\/div><\/div>').trigger("create");
        } else if (definition) {
          $("#pageDefinition").html('<div data-role="collapsible-set" data-content-theme="b" data-theme="b"><div data-role="collapsible"><h3>Entry description<\/h3><p>' + definition + '<\/p><\/div><\/div>').trigger("create");
        } else if (tags) {
          $("#pageDefinition").html('<div data-role="collapsible-set" data-content-theme="b" data-theme="b"><div data-role="collapsible"><h3>Entry keywords<\/h3><p>' + tags + '<\/p><\/div><\/div>').trigger("create");
        }
        $.mobile.changePage('#indication');
      }
       // Generate the single indications
      function listItem(title, index, tags, image, theme) {
        /*
        var image = "red.png";

        switch (components.entries[index].type) {
                case "maybe": image = "yellow.png"; break;
                case "normal": image = "green.png"; break;
         }
        */
        var listItem = '<li data-theme="' + theme + '" data-filtertext="' + tags + " " + title + '"><a style="text-align: left" href="javascript: showIndication (' + index + ')">' + (index + 1) + '. ' + title + '<img src="' + image + '"><\/a><\/li>';
        return listItem;
      }
       // Generate the list of indications
      function generateIndications(filter, listName, referer) {
        // Support back without history push state:
        referer = (referer) ? referer : "#front";
        $(".listBack").attr("href", referer);
        $(listName).html('');
        var component = '<li data-theme="f" data-role="list-divider">A. Blood component<\/li>';
        var drug = '<li data-theme="c" data-role="list-divider">B. Immunosuppressive drugs<\/li>';
        var condition = '<li data-theme="e" data-role="list-divider">C. Current or history of medical condition<\/li>';
        var neonatology = '<li data-theme="b" data-role="list-divider">D. Neonatology and obstetrics<\/li>';
        var transplant = '<li data-theme="a" data-role="list-divider">E. Stem cell and bone marrow transplant<\/li>';
        // clear search box!
        //$(".ui-input-text")[0].value = "";
        $.each(components.entries, function(i, item) {
          if (filter == "all" || item.tags.indexOf(filter) != -1) {
            switch (item.category) {
              case "component":
                component += listItem(item.title, i, item.tags, "bloodhanger.png", "f");
                break;
              case "drug":
                drug += listItem(item.title, i, item.tags, "drugs.png", "c");
                break;
              case "condition":
                condition += listItem(item.title, i, item.tags, "condition.png", "e");
                break;
              case "neonatology":
                neonatology += listItem(item.title, i, item.tags, "neonate.png", "b");
                break;
              case "transplant":
                transplant += listItem(item.title, i, item.tags, "transplant.png", "a");
                break;
            }
          }
        });
        component = (component.search('showInd') > -1) ? component : "";
        drug = (drug.search('showInd') > -1) ? drug : "";
        condition = (condition.search('showInd') > -1) ? condition : "";
        neonatology = (neonatology.search('showInd') > -1) ? neonatology : "";
        transplant = (transplant.search('showInd') > -1) ? transplant : "";
        $(listName).append(component + drug + condition + neonatology + transplant);
        $(listName).listview("refresh");
      }

      function showEvaluation() {
        window.scrollTo(0, 1);
        reminderMessage = null;
        $("#evaluationMessage").text("Please help us improve the app by completing the online evaluation form.");
        $("#evaluationButtons").show();
        if (!clickedEvaluation) {
          $('#evaluation').slideDown("slow");
        }
      }
      var clickedEvaluation = false;
       // show evaluation message after 5 minutes
      var reminderMessage = setTimeout(function() {
        showEvaluation();
      }, 5 * 60 * 1000);

      function hideEvaluation(forever) {
        clickedEvaluation = forever;
        $("#evaluationButtons").hide();
        reminderMessage = null;
        switch (forever) {
          case 1:
            $("#evaluationMessage").text("You will not be reminded again this session.");
            break;
          case 2:
            $("#evaluationMessage").text("Thank you. The online form will shortly open in a new browser window.");
            break;
          default:
            $("#evaluationMessage").text("You will be reminded again in five minutes.");
            break;
        }
        $('#evaluation').slideUp({
          duration: 2000,
          complete: function() {
            reminderMessage = null;
            reminderMessage = setTimeout(function() {
              showEvaluation();
            }, 5 * 60 * 1000);
          }
        });
      }

      function openEvaluation() {
        hideEvaluation(2);
        window.open("http://survey.it4se.com/node/32?uid=" + sessionID);
      }
       //]]>
    </script>
  </head>

  <body>
    <div id="evaluation">
      <p id="evaluationMessage" style="text-align: center">Please help improve the app by completing the online evaluation form.</p>
      <div id="evaluationButtons">
        <center> <a href="javascript:%20hideEvaluation(1);" style="background: #A55">No
          thanks</a>  <a href="javascript:%20hideEvaluation();" style="background: #088">Not now</a>  <a href="javascript:%20openEvaluation();" style="padding:10px; font-weight: bold;">Open form</a>
        </center>
      </div>
    </div>
    <div data-role="page" id="splashscreen" data-theme="e">
      <div data-role="header" data-theme="b">
        <div class="ui-grid-a">
          <div class="ui-block-a">
            <img src="logo.png" style="height: 12em; padding-left: 10px;" />
          </div>
          <div class="ui-block-b">
            <p style="text-align: right; padding-right:10px;">Alpha 0.1.1
              <br />Updated
              <br />5 Jan 2014</p>
          </div>
        </div>
      </div>
      <div data-role="content">
        <center>
          <h1>Welcome</h1>
        </center>
        <p> <b>Special Blood Request</b> aims to make it quick and easy to learn about, look up and test your knowledge of the indications for irradiated and cytomegalovirus (CMV) negative blood components. The app is designed for:</p>
        <ul class="plainlist">
          <li>Doctors who prescribe and request blood transfusions.</li>
          <li>Biomedical scientists who process blood requests.</li>
          <li>Nurses and midwives who administer or prescribe transfusions.</li>
          <li>Medical trainees who may be required to undertake any of the above.</li>
          <li>Patients with special requirements, and their families.</li>
        </ul>
        <p>Press continue to show the terms of use.</p><a href="#terms" data-role="button" data-theme="b" data-icon="arrow-r" data-iconpos="right">Continue<br /></a>
      </div>
    </div>
    <div data-role="page" id="terms" data-theme="e">
      <div data-role="header" data-theme="b">
        <div class="ui-grid-a">
          <div class="ui-block-a custom">
            <a href="#splashscreen">
              <img src="logo-up.png" style="height: 3.8em; padding-left: 5px;" />
            </a>
          </div>
          <div class="ui-block-b custom">
            <p>Terms of use</p>
          </div>
        </div>
      </div>
      <div data-role="content">
        <h1>Terms of use</h1>
        <p>Use of the app is subject to these terms. Please read them.</p>	<a href="#front" data-icon="check" data-theme="b" data-role="button">Yes, I agree to the terms</a>
        <h2>Disclaimer</h2>
        <p>Special Blood Request ("the app") was created during a PhD research project and is made available for evaluation use only. There may be inaccuracies in the content. The developers and contributors cannot be held liable for any harm resulting from the use of the app. The app is not intended to be a substitute for local hospital guidelines, professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified health provider with any questions regarding medical matters.</p>
        <p>The app is based on (but in no way endorsed by) the British Committee for Standards in Haematology (BCSH) 2010 guidelines on the irradation of blood components and the 2012 position statement on the use of CMV negative blood components by the Advisory Committee on the Safety of Blood, Tissues and Organs (SaBTO).</p>
        <p>Recommendations for irradiated and CMV negative blood components is only displayed in the app when it is indicated or contraindicated in these national UK guidelines. Guidance may not be appropriate in all patient situations. Local hospital policies may differ.</p>
        <h2>Data protection - what data we collect and how we use it</h2>
        <p>The app is developed for a research project seeking to evaluate and improve the design of clinical apps. The use of the app is therefore monitored. We may publish our findings in scholarly publications, observing the usual academic principles of anonymity, informed consent and voluntary participation. The following data is recorded:</p>
        <ul>
          <li>Which pages you visit and for how long.</li>
          <li>Information about your computing device (operating system, screen resolution, browser, IP address).</li>
          <li>Your approximate geographical location (country, city).</li>
          <li>Your responses to the quiz.</li>
          <li>Keywords that you input in the app's search functionality.</li>
        </ul>
        <p>If you choose to provide additional feedback (using the 'leave feedback' button), we may correlate your browsing behaviour with your feedback answers to help us better understand the strengths and weaknesses of the app design. To do this we store a browser cookie on your device.</p>
        <p>We do not collect any personally identifying information, unless you disclose this through the online feedback form.</p>
        <h2>No warranty</h2>
        <p>THE SOFTWARE IS PROVIDED "AS IS", WITHOUT WARRANTY OF ANY KIND, EXPRESS OR IMPLIED, INCLUDING BUT NOT LIMITED TO THE WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE AND NONINFRINGEMENT. IN NO EVENT SHALL THE AUTHORS OR COPYRIGHT HOLDERS BE LIABLE FOR ANY CLAIM, DAMAGES OR OTHER LIABILITY, WHETHER IN AN ACTION OF CONTRACT, TORT OR OTHERWISE, ARISING FROM, OUT OF OR IN CONNECTION WITH THE SOFTWARE OR THE USE OR OTHER DEALINGS IN THE SOFTWARE.</p>	<a href="#front" data-icon="check" data-theme="b" data-role="button">Yes, I agree to the terms</a>
      </div>
    </div>
    <div data-role="page" id="front" data-theme="e">
      <div data-role="header" data-theme="b">
        <div class="ui-grid-b">
          <div class="ui-block-a">
            <a href="#splashscreen">
              <img src="logo-up.png" style="height: 3.8em; padding-left: 5px;" />
            </a>
          </div>
          <div class="ui-block-b">
            <p>Main Menu</p>
          </div>
          <div class="ui-block-c"> <a href="#about" data-role="button">About</a>
          </div>
        </div>
      </div>
      <div data-role="content">
        <center>
          <h1>Main menu</h1>
          <div class="ui-grid-a" style="max-width: 500px">
            <div class="ui-block-a"> <a href="#learn" data-iconpos="top" data-icon="info" data-role="button" data-theme="b">1. Information<br />
              <br /></a>
            </div>
            <div class="ui-block-b"> <a href="#list" data-iconpos="top" data-icon="search" data-role="button" data-theme="b">2. Indications<br />
              <br /></a>
            </div>
            <div class="ui-block-a"> <a href="#step1" data-iconpos="top" data-icon="check" data-role="button" data-theme="b">3. Checklist<br />
              <br /></a>
            </div>
            <div class="ui-block-b"> <a href="#quiz" data-iconpos="top" data-icon="star" data-role="button" data-theme="b">4. Quiz<br />
              <br /></a>
            </div>
          </div>
          <p>Press a button.</p>
        </center>
      </div>
    </div>
    <div data-role="page" id="learn" data-theme="e" data-prev="#front" data-next="#safety">
      <div data-role="header" data-theme="b">
        <div class="ui-grid-a">
          <div class="ui-block-a custom">
            <a href="#front">
              <img src="logo-up.png" style="height: 3.8em; padding-left: 5px;" />
            </a>
          </div>
          <div class="ui-block-b custom">
            <p>1. Information</p>
          </div>
        </div>
      </div>
      <div data-role="content">
        <h1>1. Information</h1>
        <br />
        <ul data-role="listview" data-inset="false" data-theme="b" data-dividertheme="a">
          <li data-role="list-divider">Table of contents</li>
          <li> <a href="#safety">1.1 Patient safety</a>
          </li>
          <li> <a href="#mistakes">1.2 Mistakes</a>
          </li>
          <li> <a href="#causes">1.3 Causes</a>
          </li>
          <li> <a href="#prevention">1.4 Prevention</a>
          </li>
          <li> <a href="#references">1.5 References</a>
          </li>
          <li> <a href="#glossary">1.6 Glossary</a>
          </li>
        </ul>
        <br />
        <p>Select a topic from the list or tap the button below to start from the beginning.</p><a href="#safety" data-role="button" data-theme="b" data-icon="arrow-r" data-iconpos="right">1.1 Patient safety</a>
      </div>
    </div>
    <div data-role="page" id="safety" data-theme="e" data-prev="#learn" data-next="#mistakes">
      <div data-role="header" data-theme="b">
        <div class="ui-grid-a">
          <div class="ui-block-a custom">
            <a href="#learn">
              <img src="logo-up.png" style="height: 3.8em; padding-left: 5px;" />
            </a>
          </div>
          <div class="ui-block-b custom">
            <p>1.1 Patient safety</p>
          </div>
        </div>
      </div>
      <div data-role="content">
        <h3>1.1 Patient safety</h3>
        <p>Failure to provide <a href="javascript:%20showWord('irradiation')" class="definition">irradiated</a> cellular <a href="javascript:%20showWord('components')" class="definition">blood components</a>
          may expose <a href="javascript:showWord('at-risk')" class="definition">at-risk
          patients</a> to transfusion-associated Graft versus Host Disease <a href="javascript:%20showWord('gvhd')" class="definition">TA-GvHD</a>. This is a very rare, but life-threatening condition <a href="javascript:%20showSource('bcsh2010');" class="reference">BCSH 2010, p.37</a>.</p>
        <p>Red cells and platelets supplied through the UK Blood Services are <a href="javascript:%20showWord('leucodepletion')" class="definition">leucocyte
          depleted</a>  <a href="javascript:%20showSource('bcsh2010');" class="reference">SaBTO 2012, p.1</a>. However removal of leucocytes (white cells) is not a substitute for irradiation, which prevents TA-GvHD by inactivating residual donor lymphocytes <a href="javascript:%20showSource('bcsh2010');" class="reference">BCSH 2010, p.49</a>.</p>
        <p>Although leucodepletion provides significant protection against <a href="javascript:%20showWord('cmv')" class="definition">cytomegalovirus</a> (CMV) infection, cellular blood components should be provided as CMV negative to protect vulnerable patients against transfusion-transmitted CMV infection <a href="javascript:%20showSource('sabto2012');" class="reference">SaBTO
          2012</a>.</p>
        <div class="ui-grid-a">
          <div class="ui-block-a"> <a href="#learn" data-theme="b" data-role="button" data-icon="arrow-l" data-iconpos="left">1. Information</a>
          </div>
          <div class="ui-block-b"> <a href="#mistakes" data-theme="b" data-role="button" data-icon="arrow-r" data-iconpos="right">1.2 Mistakes</a>
          </div>
        </div>
      </div>
    </div>
    <div data-role="page" id="mistakes" data-theme="e" data-prev="#safety" data-next="#causes">
      <div data-role="header" data-theme="b">
        <div class="ui-grid-a">
          <div class="ui-block-a custom">
            <a href="#learn">
              <img src="logo-up.png" style="height: 3.8em; padding-left: 5px;" />
            </a>
          </div>
          <div class="ui-block-b custom">
            <p>1.2 Mistakes</p>
          </div>
        </div>
      </div>
      <div data-role="content">
        <h3>1.2 Mistakes</h3>
        <p>Almost three million blood components are issued annually in UK <a href="javascript:%20showSource('shot2009');" class="reference">SHOT 2009, p.11</a>. Of these, approximately 10% are irradiated <a href="javascript:%20showSource('shot2010');" class="reference">SHOT 2010, p.129</a>.</p>
        <p>In the last five years, more than five hundred mistakes involving irradiated and CMV negative blood components were reported to the Serious Hazards of Transfusion (SHOT) UK haemovigilance scheme (Figure 1).</p>
        <p>These were incidents where blood components failed to be provided as irradiated and/or CMV negative to at-risk patients according to guidelines.</p>
        <img src="graph.png" style="display: block; margin: 0 auto; width:100%;" />
        <p style="line-height: 1.1em;"> <b>Figure 1:</b> Specific Requirements Not Met (SRNM) reports by year and source of error. Clinical errors include failure to communicate the need for special components to the lab. Lab errors are when the request was made but not acted upon <a href="javascript:%20showSource('shot2010');" class="reference">SHOT 2010, p.27</a>. SHOT data used with permission and provided courtesy of Dr. Paula Bolton-Maggs, Debbi Poles and Alison Watts.</p>
        <div class="ui-grid-a">
          <div class="ui-block-a"> <a href="#safety" data-theme="b" data-role="button" data-icon="arrow-l" data-iconpos="left">1.1 Patient safety</a>
          </div>
          <div class="ui-block-b"> <a href="#causes" data-theme="b" data-role="button" data-icon="arrow-r" data-iconpos="right">1.3 Causes</a>
          </div>
        </div>
      </div>
    </div>
    <div data-role="page" id="causes" data-theme="e" data-prev="#mistakes" data-next="#prevention">
      <div data-role="header" data-theme="b">
        <div class="ui-grid-a">
          <div class="ui-block-a custom">
            <a href="#learn">
              <img src="logo-up.png" style="height: 3.8em; padding-left: 5px;" />
            </a>
          </div>
          <div class="ui-block-b custom">
            <p>1.3 Causes</p>
          </div>
        </div>
      </div>
      <div data-role="content">
        <h3>1.3 Causes</h3>
        <p>There are many underlying reasons for why special requirements fail to be provided to at-risk patients, as these SHOT cases illustrate:</p>
        <div data-role="collapsible-set" data-theme="f" data-content-theme="f">
          <div data-role="collapsible" data-collapsed-icon="alert">
            <h3>Poor knowledge of the indications</h3>
            <p>"The admitting doctor noted the past history of Hodgkin's disease but was not aware of the requirements for irradiated blood." <a href="javascript:%20showSource('shot2011');" class="reference">SHOT 2011,
              p.26</a>
            </p>
          </div>
          <div data-role="collapsible" data-collapsed-icon="alert">
            <h3>Request form not filled out correctly</h3>
            <p>"A request form for blood components for a patient with CLL on fludarabine was completed by a haematology nurse, and checked and signed by a junior doctor who also prescribed the components. The need for irradiated blood was not indicated on the request form or the prescription." <a href="javascript:%20showSource('shot2008');" class="reference">SHOT 2008,
              p.46</a>
            </p>
          </div>
          <div data-role="collapsible" data-collapsed-icon="alert">
            <h3>Failure to check medical record</h3>
            <p>"An elderly man was transfused 9 units of blood for chronic anaemia. Subsequently a haematology registrar found that he had been treated with cladarabine several years before." <a href="javascript:%20showSource('shot2012');" class="reference">SHOT 2012,
              p.32</a>
            </p>
          </div>
          <div data-role="collapsible" data-collapsed-icon="alert">
            <h3>Shared patient care</h3>
            <p>"A patient was transferred from his primary hospital, where he had undergone a stem-cell transplant, to another hospital within the same Trust in order to access an ITU bed. [...] Irradiated components were not requested due to a lack of communication between the clinicians, and the laboratory records were separate from those at the originating hospital." <a href="javascript:%20showSource('shot2010');" class="reference">SHOT
              2010, p.41</a>
            </p>
          </div>
          <div data-role="collapsible" data-collapsed-icon="alert">
            <h3>Wrong blood component transfused</h3>
            <p>"No patient identification was taken to the blood fridge, and as a result the wrong unit of red cells was removed by a registered nurse and taken to the ward for an 81-year-old female patient with chronic lymphocytic leukaemia (CLL). On the ward another nurse administering the transfusion assumed that the checks had been completed, and because of this assumption no bedside checks were performed. The patient received non-irradiated group A D positive red cells, instead of irradiated O D positive red cells. The error was noticed when the patient asked whether the unit was irradiated. Consequently &lt;50 mL was transfused." <a href="javascript:%20showSource('shot2008');" class="reference">SHOT 2008,
              p.31</a>
            </p>
          </div>
          <div data-role="collapsible" data-collapsed-icon="alert">
            <h3>Incorrect use of warning flags</h3>
            <p>"A patient required irradiated blood because of previous chemotherapy. The transfusion laboratory had received notification of this special requirement and added the information to the LIMS. The special requirement flag was subsequently removed from the LIMS in error. From the time the flag was removed to the time it was discovered, the patient had received 15 units of red cells and 5 units of platelets that had not been irradiated." <a href="javascript:%20showSource('shot2012');" class="reference">SHOT
              2012, p.56</a>
            </p>
          </div>
        </div>
        <p>Press to expand list items.</p>
        <div class="ui-grid-a">
          <div class="ui-block-a"> <a href="#mistakes" data-theme="b" data-role="button" data-icon="arrow-l" data-iconpos="left">1.2 Mistakes</a>
          </div>
          <div class="ui-block-b"> <a href="#prevention" data-theme="b" data-role="button" data-icon="arrow-r" data-iconpos="right">1.4 Prevention</a>
          </div>
        </div>
      </div>
    </div>
    <div data-role="page" id="prevention" data-theme="e" data-prev="#causes" data-next="#references">
      <div data-role="header" data-theme="b">
        <div class="ui-grid-a">
          <div class="ui-block-a custom">
            <a href="#learn">
              <img src="logo-up.png" style="height: 3.8em; padding-left: 5px;" />
            </a>
          </div>
          <div class="ui-block-b custom">
            <p>1.4 Prevention</p>
          </div>
        </div>
      </div>
      <div data-role="content">
        <h3>1.4 Prevention</h3>
        <p>SHOT has made several recommendations aimed at reducing mistakes. Some of these are to:</p>
        <div data-role="collapsible-set" data-theme="h" data-content-theme="h">
          <div data-role="collapsible" data-collapsed-icon="check">
            <h3>Increase knowledge of special requirements</h3>
            <p>"All haematology units must devise specific educational programmes for all their staff members providing the rationale and indications for specialist components and this information should be accessible at the time of making the requests for blood components." <a href="javascript:%20showSource('shot2011');" class="reference">SHOT 2011,
              p.28</a>
            </p>
            <p>"The importance of irradiation, and the rationale behind it should be emphasised during teaching of junior haematology and oncology doctors. This education is part of the curriculum for specialist trainees, but the junior pre-specialist doctors in these areas may remain ignorant despite being frequently called upon to order components." <a href="javascript:%20showSource('shot2008');" class="reference">SHOT 2008,
              p.26</a>
            </p>
          </div>
          <div data-role="collapsible" data-collapsed-icon="check">
            <h3>Ensure special blood components are ordered correctly</h3>
            <p>"Local mechanisms for ordering and prescribing components need to facilitate correct ordering, and remind clinical and laboratory personnel where possible" <a href="javascript:%20showSource('shot2011');" class="reference">SHOT 2011, p.26</a>
            </p>
          </div>
          <div data-role="collapsible" data-collapsed-icon="check">
            <h3>Educate patients who have special requirements</h3>
            <p>"Patients who require irradiated and other special products should be provided with an appropriate card [...] Patients with cards noting special requirements should be educated about their meaning and importance, in particular always to show these to clinical staff on admission to any hospital." <a href="javascript:%20showSource('shot2012');" class="reference">SHOT 2012, p.34</a>
            </p>
          </div>
          <div data-role="collapsible" data-collapsed-icon="check">
            <h3>Conduct thorough bedside checks</h3>
            <p>"The final 'bedside' check is the last opportunity to ensure that the correct unit or component has been collected for the patient receiving the transfusion. Complete and thorough bedside checks involving one or two staff members must be completed independently and without interruption. " <a href="javascript:%20showSource('shot2011');" class="reference">SHOT
              2013, p.61</a>
            </p>
            <p>"Every person in the transfusion process must perform rigorous identity checks at each point and ensure that the component collected is the one prescribed. The use of a transfusion checklist is recommended." <a href="javascript:%20showSource('shot2011');" class="reference">SHOT 2013,
              p.62</a>
            </p>
          </div>
          <div data-role="collapsible" data-collapsed-icon="check">
            <h3>Use warning flags with care</h3>
            <p>"Computer prompts/warnings/flags are a valuable tool for trying to prevent human error through 'slips'; but staff must also have the underpinning knowledge to understand and act appropriately to a warning." <a href="javascript:%20showSource('shot2011');" class="reference">SHOT 2012,
              p.7</a>
            </p>
            <p>"The addition of these warnings/flags/notes is a manual procedure and is itself prone to error and should be controlled, for example, entered by one BMS and checked by a second." <a href="javascript:%20showSource('shot2011');" class="reference">SHOT 2012,
              p.51</a>
            </p>
          </div>
        </div>
        <p>Press to expand list items.</p>
        <p>For more details and recommendations, please refer to the latest SHOT report. <a href="javascript:%20showSource('shot2013');" class="reference">SHOT 2013</a>
        </p>
        <div class="ui-grid-a">
          <div class="ui-block-a"> <a href="#causes" data-theme="b" data-role="button" data-icon="arrow-l" data-iconpos="left">1.3 Causes</a>
          </div>
          <div class="ui-block-b"> <a href="#references" data-theme="b" data-role="button" data-icon="arrow-r" data-iconpos="right">1.5 References</a>
          </div>
        </div>
      </div>
    </div>
    <div data-role="page" id="howto" data-theme="e" data-prev="#prevention" data-next="#references">
      <div data-role="header" data-theme="b">
        <div class="ui-grid-a">
          <div class="ui-block-a custom">
            <a href="#learn">
              <img src="logo-up.png" style="height: 3.8em; padding-left: 5px;" />
            </a>
          </div>
          <div class="ui-block-b custom">
            <p>1.5 How to use the app</p>
          </div>
        </div>
      </div>
      <div data-role="content">
        <div class="ui-grid-a">
          <div class="ui-block-a"> <a href="#prevention" data-theme="b" data-role="button" data-icon="arrow-l" data-iconpos="left">1.4 Prevention</a>
          </div>
          <div class="ui-block-b"> <a href="#references" data-theme="b" data-role="button" data-icon="arrow-r" data-iconpos="right">1.6 References</a>
          </div>
        </div>
      </div>
    </div>
    <div data-role="page" id="references" data-theme="e" data-prev="#howto" data-next="#glossary">
      <div data-role="header" data-theme="b">
        <div class="ui-grid-a">
          <div class="ui-block-a custom">
            <a href="#learn">
              <img src="logo-up.png" style="height: 3.8em; padding-left: 5px;" />
            </a>
          </div>
          <div class="ui-block-b custom">
            <p>1.5 References</p>
          </div>
        </div>
      </div>
      <div data-role="content">
        <h3>1.5 References</h3>
        <div class="ui-grid-a">
          <div class="ui-block-a"> <a href="#" data-icon="arrow-d" data-role="button" data-theme="b" id="expandReferences">Expand all</a>
          </div>
          <div class="ui-block-b"> <a href="#" data-icon="arrow-u" data-iconpos="right" data-role="button" data-theme="b" id="collapseReferences">Collapse all</a>
          </div>
        </div>
        <div data-role="collapsible-set" data-theme="b" data-content-theme="b" data-inset="true" id="referenceCollection">
          <div data-role="collapsible" id="bcsh2010">
            <h3>BCSH (2010)</h3>
            <p>Treleaven, J., Gennery, A., Marsh, J., Norfolk, D., Page, L., Parker, A., Saran, F., Thurston, J. and Webb, D. (2011), Guidelines on the use of irradiated blood components prepared by the British Committee for Standards in Haematology blood transfusion task force. British Journal of Haematology, 152: 35-51. doi: 10.1111/j.1365-2141.2010.08444.x</p>
            <div class="ui-grid-a">
              <div class="ui-block-a"> <a href="#" data-rel="back" data-icon="arrow-l" data-role="button" data-theme="b">Back</a>
              </div>
              <div class="ui-block-b"> <a href="http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2141.2010.08444.x/full" target="_blank" data-icon="arrow-r" data-iconpos="right" data-role="button" data-theme="b">Open</a>
              </div>
            </div>
          </div>
          <div data-role="collapsible" id="htm2007">
            <h3>HTM (2007)</h3>
            <p>DBL McClelland (ed) (2007) Handbook of Transfusion Medicine, 4th Ed. Published in the UK by The Stationary Office.</p>
            <div class="ui-grid-a">
              <div class="ui-block-a"> <a href="#" data-rel="back" data-icon="arrow-l" data-role="button" data-theme="b">Back</a>
              </div>
              <div class="ui-block-b"> <a href="http://www.transfusionguidelines.org.uk/index.aspx?Publication=HTM" target="_blank" data-icon="arrow-r" data-iconpos="right" data-role="button" data-theme="b">Open</a>
              </div>
            </div>
          </div>
          <div data-role="collapsible" id="mesh2013">
            <h3>MESH (2013)</h3>
            <p>Medical Subject Headings (2013) published by the U.S. National Library of Medicine, National Institutes of Health.</p>
            <div class="ui-grid-a">
              <div class="ui-block-a"> <a href="#" data-rel="back" data-icon="arrow-l" data-role="button" data-theme="b">Back</a>
              </div>
              <div class="ui-block-b"> <a href="http://www.nlm.nih.gov/mesh/2013/mesh_browser/" target="_blank" data-icon="arrow-r" data-iconpos="right" data-role="button" data-theme="b">Open</a>
              </div>
            </div>
          </div>
          <div data-role="collapsible" id="nhsgenetics">
            <h3>NHS NGGEC (no year)</h3>
            <p>NHS National Genetics and Genomics Education Centre, glossary item "First-degree relative".</p>
            <div class="ui-grid-a">
              <div class="ui-block-a"> <a href="#" data-rel="back" data-icon="arrow-l" data-role="button" data-theme="b">Back</a>
              </div>
              <div class="ui-block-b"> <a href="http://www.geneticseducation.nhs.uk/genetics-glossary/181-first-degree-relative" target="_blank" data-icon="arrow-r" data-iconpos="right" data-role="button" data-theme="b">Open</a>
              </div>
            </div>
          </div>
          <div data-role="collapsible" id="obu2010">
            <h3>OBU (2010)</h3>
            <p>McClelland DBL, Pirie E, Franklin IM (2010) for the EU Optimal Use of Blood Project Partners. The Optimal Blood Use Manual. Published by Scottish National Blood Transfusion Service.</p>
            <div class="ui-grid-a">
              <div class="ui-block-a"> <a href="#" data-rel="back" data-icon="arrow-l" data-role="button" data-theme="b">Back</a>
              </div>
              <div class="ui-block-b"> <a href="http://www.optimalblooduse.eu" target="_blank" data-icon="arrow-r" data-iconpos="right" data-role="button" data-theme="b">Open</a>
              </div>
            </div>
          </div>
          <div data-role="collapsible" id="sabto2012">
            <h3>SaBTO (2012)</h3>
            <p>Advisory Committee on the Safety of Blood, Tissues and Organs (SaBTO) (2012) Position statement on cytomegalovirus tested blood components.</p>
            <div class="ui-grid-a">
              <div class="ui-block-a"> <a href="#" data-rel="back" data-icon="arrow-l" data-role="button" data-theme="b">Back</a>
              </div>
              <div class="ui-block-b"> <a href="https://www.gov.uk/government/publications/sabto-report-of-the-cytomegalovirus-steering-group" target="_blank" data-icon="arrow-r" data-iconpos="right" data-role="button" data-theme="b">Open</a>
              </div>
            </div>
          </div>
          <div data-role="collapsible" id="shot2008">
            <h3>SHOT (2008)</h3>
            <p>Taylor C, Cohen H, Jones H, et al (2008), on behalf of the Serious Hazards of Transfusion (SHOT) Steering Group. The 2007 Annual SHOT Report.</p>
            <div class="ui-grid-a">
              <div class="ui-block-a"> <a href="#" data-rel="back" data-icon="arrow-l" data-role="button" data-theme="b">Back</a>
              </div>
              <div class="ui-block-b"> <a href="http://www.shotuk.org/shot-reports/reports-and-summaries-2007/" target="_blank" data-icon="arrow-r" data-iconpos="right" data-role="button" data-theme="b">Open</a>
              </div>
            </div>
          </div>
          <div data-role="collapsible" id="shot2009">
            <h3>SHOT (2009)</h3>
            <p>Taylor C (Ed.), Cohen H, Mold D, Jones H, et al (2009), on behalf of the Serious Hazards of Transfusion (SHOT) Steering Group. The 2008 Annual SHOT Report.</p>
            <div class="ui-grid-a">
              <div class="ui-block-a"> <a href="#" data-rel="back" data-icon="arrow-l" data-role="button" data-theme="b">Back</a>
              </div>
              <div class="ui-block-b"> <a href="http://www.shotuk.org/shot-reports/reports-and-summaries-2008/" target="_blank" data-icon="arrow-r" data-iconpos="right" data-role="button" data-theme="b">Open</a>
              </div>
            </div>
          </div>
          <div data-role="collapsible" id="shot2010">
            <h3>SHOT (2010)</h3>
            <p>Taylor C (Ed.), Cohen H, Mold D, Jones H, et al (2010), on behalf of the Serious Hazards of Transfusion (SHOT) Steering Group. The 2009 Annual SHOT Report.</p>
            <div class="ui-grid-a">
              <div class="ui-block-a"> <a href="#" data-rel="back" data-icon="arrow-l" data-role="button" data-theme="b">Back</a>
              </div>
              <div class="ui-block-b"> <a href="http://www.shotuk.org/shot-reports/report-and-summary-2009/" target="_blank" data-icon="arrow-r" data-iconpos="right" data-role="button" data-theme="b">Open</a>
              </div>
            </div>
          </div>
          <div data-role="collapsible" id="shot2012">
            <h3>SHOT (2012)</h3>
            <p>Bolton-Maggs, P (Ed) and Cohen, H (2012) on behalf of the Serious Hazards of Transfusion (SHOT) Steering Group. The 2011 Annual SHOT Report.</p>
            <div class="ui-grid-a">
              <div class="ui-block-a"> <a href="#" data-rel="back" data-icon="arrow-l" data-role="button" data-theme="b">Back</a>
              </div>
              <div class="ui-block-b"> <a href="http://www.shotuk.org/shot-reports/shot-annual-report-summary-2011/" target="_blank" data-icon="arrow-r" data-iconpos="right" data-role="button" data-theme="b">Open</a>
              </div>
            </div>
          </div>
          <div data-role="collapsible" id="shot2013">
            <h3>SHOT (2013)</h3>
            <p>Bolton-Maggs P (Ed), Poles D, Watt A, Thomas D and Cohen H (2013) on behalf of the Serious Hazards of Transfusion (SHOT) Steering Group. The 2012 Annual SHOT Report.</p>
            <div class="ui-grid-a">
              <div class="ui-block-a"> <a href="#" data-rel="back" data-icon="arrow-l" data-role="button" data-theme="b">Back</a>
              </div>
              <div class="ui-block-b"> <a href="http://www.shotuk.org/shot-reports/report-summary-and-supplement-2012/" target="_blank" data-icon="arrow-r" data-iconpos="right" data-role="button" data-theme="b">Open</a>
              </div>
            </div>
          </div>
          <div data-role="collapsible" id="ukbts2012">
            <h3>UKBTS (2012)</h3>
            <p>Joint UKBTS / HPA Professional Advisory Committee (2012) Position Statement on Granulocyte Therapy. Revised by Edwin Massey, Simon Stanworth and Rebecca Cardigan at the request of the Standing Advisory Committee on Blood Components.</p>
            <div class="ui-grid-a">
              <div class="ui-block-a"> <a href="#" data-rel="back" data-icon="arrow-l" data-role="button" data-theme="b">Back</a>
              </div>
              <div class="ui-block-b"> <a href="http://www.transfusionguidelines.org.uk/index.aspx?Publication=DL&amp;pageid=1336" target="_blank" data-icon="arrow-r" data-iconpos="right" data-role="button" data-theme="b">Open</a>
              </div>
            </div>
          </div>
        </div>
        <p>Press to expand an entry. All documents open in a new window.</p>
        <div class="ui-grid-a">
          <div class="ui-block-a"> <a href="#prevention" data-theme="b" data-role="button" data-icon="arrow-l" data-iconpos="left">1.4 Prevention</a>
          </div>
          <div class="ui-block-b"> <a href="#glossary" data-theme="b" data-role="button" data-icon="arrow-r" data-iconpos="right">1.6 Glossary</a>
          </div>
        </div>
      </div>
    </div>
    <div data-role="page" id="glossary" data-theme="e" data-prev="#references" data-next="#front">
      <div data-role="header" data-theme="b">
        <div class="ui-grid-a">
          <div class="ui-block-a custom">
            <a href="#learn">
              <img src="logo-up.png" style="height: 3.8em; padding-left: 5px;" />
            </a>
          </div>
          <div class="ui-block-b custom">
            <p>1.6 Glossary</p>
          </div>
        </div>
      </div>
      <div data-role="content">
        <h3>1.6 Glossary</h3>
        <div class="ui-grid-a">
          <div class="ui-block-a"> <a href="#" data-icon="arrow-d" data-role="button" data-theme="f" id="expandGlossary">Expand all</a>
          </div>
          <div class="ui-block-b"> <a href="#" data-icon="arrow-u" data-iconpos="right" data-role="button" data-theme="f" id="collapseGlossary">Collapse all</a>
          </div>
        </div>
        <div data-role="collapsible-set" data-inset="true" data-theme="f" data-content-theme="c" id="glossaryCollection">
          <div data-role="collapsible" id="at-risk">
            <h3>At-risk patients</h3>
            <p>Please consult the list of indications to determine which patient groups are considered at risk of transfusion-associated <a href="javascript:%20showWord('gvhd')" class="definition">Graft versus Host
              Disease</a> (TA-GvHD) and transfusion-transmitted <a href="javascript:%20showWord('cmv')" class="definition">cytomegalovirus</a>
              (CMV) infection.</p>
            <div class="ui-grid-a">
              <div class="ui-block-a"> <a href="#" data-rel="back" data-icon="arrow-l" data-role="button" data-theme="b">Back</a>
              </div>
              <div class="ui-block-b"> <a href="#list" data-icon="arrow-r" data-iconpos="right" data-role="button" data-theme="b">Indications</a>
              </div>
            </div>
          </div>
          <div data-role="collapsible" id="components">
            <h3>Blood components</h3>
            <p>Blood is separated into five components: red cells, platelets, white cells, fresh frozen plasma and cryoprecipitate <a href="javascript:%20showSource('htm2007')" class="reference">HTM 2007, p. 1</a>. These can be classified into cellular and non-cellular (plasma) components.</p>
            <h3>Cellular blood components</h3>
            <p>Platelets, red cells and white cells are cellular blood components that contain leucocytes (white cells).</p>
            <p>Lymphocytes (a type of white cell) can cause <a href="javascript:%20showWord('gvhd')" class="definition">TA-GvHD</a>. Hence cellular blood components, even if <a href="javascript:%20showWord('leucodepletion')" class="definition">leucodepleted</a>, must be <a href="javascript:%20showWord('irradiation')" class="definition">irradiated</a>
              to deactivate any residual lymphocytes before transfusion to <a href="javascript:%20showWord('at-risk')" class="definition">at-risk patients</a>
              <a href="javascript:%20showSource('htm2007')" class="reference">HTM 2007,
              p. 41</a>.</p>
            <p>The only exception to this rule is cryopreserved red cells after deglycerolization, because these are washed free of leucocytes <a href="javascript:%20showSource('bcsh2010')" class="reference">BCSH 2010, p.
              42</a>.</p>
            <p>Monocytes (another type of white cell) may carry latent <a href="javascript:%20showWord('cmv')" class="definition">cytomegalovirus</a>
              (CMV). For this reason SaBTO recommend cellular blood components be provided leucodepleted and CMV negative to high risk patients <a href="javascript:%20showSource('sabto2012')" class="reference">SaBTO 2012</a>.</p>
            <h3>Non-cellular (plasma) blood components</h3>
            <p>In contrast, fresh frozen plasma, cryoprecipitate or fractionated plasma products are non-cellular blood components that do not contain white cells.</p>
            <p>Non-cellular blood components do not need to be irradiated or provided as CMV negative (even though CMV can occurr freely in plasma) <a href="javascript:%20showSource('sabto2012')" class="reference">SaBTO 2012, p.
              2</a>.</p><a href="#" data-rel="back" data-icon="arrow-l" data-role="button" data-theme="b">Back</a>
          </div>
          <div data-role="collapsible" id="cmv">
            <h3>Cytomegalovirus (CMV)</h3>
            <p>"Cytomegalovirus is a herpes virus that gives rise to chronic, persistent and, for the most part, asymptomatic infection in a majority of adults worldwide. More severe disease may occur in certain groups, such as foetuses, neonates and immunocompromised adults." <a href="javascript:%20showSource('sabto2012');" class="reference">SaBTO 2012</a>
            </p>
            <p>"Cytomegalovirus (CMV) infection can cause serious morbidity in immunocompromised CMV-negative patients. The risk can be minimised by the use of CMV-antibody-negative (seronegative) blood components. <a href="javascript:%20showWord('leucodepletion')" class="definition">Leucocyte
              depletion</a> also confers some protection since the virus is associated with white blood cells." <a href="javascript:%20showSource('htm2007');" class="reference">HTM 2007, p. 41</a>
            </p><a href="#" data-rel="back" data-icon="arrow-l" data-role="button" data-theme="b">Back</a>
          </div>
          <div data-role="collapsible" id="relatives">
            <h3>First- or second-degree relatives</h3>
            <p>"The 'degree of relationship' describes the proportion of genes shared by two blood relatives. A person's first degree relative is a parent, sibling, or child. A first degree relative shares about half of their genes with the person.</p>
            <p>A second degree relative of a person is an uncle, aunt, nephew, niece, grandparent, grandchild or half- sibling. A second degree relative shares about one quarter of their genes with the person." <a href="javascript:%20showSource('nhsgenetics');" class="reference">NHS NGGEC no year</a>.</p> <a href="#" data-rel="back" data-icon="arrow-l" data-role="button" data-theme="b">Back</a>
          </div>
          <div data-role="collapsible" id="irradiation">
            <h3>Irradiation</h3>
            <p>"The major technology for preventing <a href="javascript:%20showWord('gvhd')" class="definition">TA-GvHD</a> is irradiation of blood components to inactivate residual lymphocytes. Gamma rays and X-rays are similar in their ability to inactivate T lymphocytes in blood components at a given absorbed dose." <a href="javascript:%20showSource('bcsh2010');" class="reference">BCSH 2010,
              p.41</a>
            </p>
            <p>"In the UK, a minimum of 25 Gy is recommended, but with the dose to any bag in the container not exceeding 50 Gy. To ensure this dose distribution is achieved, consultation with supporting physicists is mandatory." <a href="javascript:%20showSource('bcsh2010');" class="reference">BCSH 2010,
              p.41</a>
            </p>
            <p>"For at-risk patients, all red cell, platelet and granulocyte concentrates should be irradiated except cryopreserved red cells after deglycerolization. It is not necessary to irradiate fresh frozen plasma, cryoprecipitate or fractionated plasma products (1B)." <a href="javascript:%20showSource('bcsh2010');" class="reference">BCSH 2010,
              p.36</a>
            </p><a href="#" data-rel="back" data-icon="arrow-l" data-role="button" data-theme="b">Back</a>
          </div>
          <div data-role="collapsible" id="leucodepletion">
            <h3>Leucodepletion</h3>
            <p>Red cells and platelets supplied through the UK blood services are leucocyte depleted <a href="javascript:%20showSource('bcsh2010');" class="reference">SaBTO 2012, p.1</a>.</p>
            <p>"Removal of leucocytes to a level of less than one million per component by filtration or during collection of blood components by apheresis is normal practice in a number of EU countries. Advantages of leucodepletion include a marked reduction in alloimmunisation to HLA antigens and in the risk of infection by intracellular viruses such as cytomegalovirus. Leucodepletion of red cells may also be associated with improved outcomes in some groups of patients." <a href="javascript:%20showSource('obu2010');" class="reference">OBU 2010</a>
            </p><a href="#" data-rel="back" data-icon="arrow-l" data-role="button" data-theme="b">Back</a>
          </div>
          <div data-role="collapsible" id="gvhd">
            <h3>Transfusion-Associated Graft versus Host Disease</h3>
            <p>"TA-GvHD is a very rare but usually fatal complication following transfusion of lymphocyte-containing blood components. [---] The risk associated with an individual transfusion depends on the number and viability of contaminating lymphocytes, susceptibility of the recipient's immune system to their engraftment and degree of immunological (HLA) disparity between donor and patient." <a href="javascript:%20showSource('bcsh2010');" class="reference">BCSH
              2010, p.37</a>
            </p>
            <p>"Transfused donor lymphocytes which are compatible with the recipient, but which recognise the recipient as foreign, can engraft and initiate TA-GvHD. Patients develop skin rash, diarrhoea and abnormal liver function, and deteriorate, with bone marrow failure and death from infection usually within two to three weeks of transfusion." <a href="javascript:%20showSource('htm2007');" class="reference">HTM 2007, p.41</a>
            </p>
            <p>"Patients at risk are immunocompromised or those who receive transfusion from a first- or second-degree relative (due to the sharing of an HLA haplotype)." <a href="javascript:%20showSource('htm2007');" class="reference">HTM 2007, p.62</a>
            </p><a href="#" data-rel="back" data-icon="arrow-l" data-role="button" data-theme="b">Back</a>
          </div>
        </div>
        <p>Press to expand an entry.</p>
        <div class="ui-grid-a">
          <div class="ui-block-a"> <a href="#references" data-theme="b" data-role="button" data-icon="arrow-l" data-iconpos="left">1.5 References</a>
          </div>
          <div class="ui-block-b"> <a href="#front" data-theme="b" data-role="button" data-icon="arrow-r" data-iconpos="right">Main menu</a>
          </div>
        </div>
      </div>
    </div>
    <div data-role="page" id="list" data-theme="e">
      <div data-role="header" data-theme="b">
        <div class="ui-grid-a">
          <div class="ui-block-a custom">
            <a href="#front" class="listBack">
              <img src="logo-up.png" style="height: 3.8em; padding-left: 5px;" />
            </a>
          </div>
          <div class="ui-block-b custom">
            <p>2. Indications</p>
          </div>
        </div>
      </div>
      <div data-role="content">
        <h1>2. Indications</h1>
        <p>Select an item in the list to view details. Type a keyword into the search box to quickly find indications.</p>
        <ul id="allIndications" data-filter-theme="c" data-role="listview" data-filter-placeholder="Enter keyword here" data-filter="true" data-dividertheme="d" style="margin-bottom: 20px"></ul>
        <h3>You have reached the end of the list.</h3>
      </div>
    </div>
    <div data-role="page" id="subset" data-theme="e">
      <div data-role="header" data-theme="b">
        <div class="ui-grid-a">
          <div class="ui-block-a custom">
            <a href="#step1">
              <img src="logo-up.png" style="height: 3.8em; padding-left: 5px;" />
            </a>
          </div>
          <div class="ui-block-b custom">
            <p>3. Checklist</p>
          </div>
        </div>
      </div>
      <div data-role="content">
        <h1>3. Checklist (3/3)</h1>
        <p id="checklistInstructions">Please go back and re-open the checklist page.</p>
        <br />
        <ul id="subsetIndications" data-role="listview" style="margin-bottom: 20px"></ul><a href="#step2" data-role="button" data-icon="arrow-l" data-iconpos="left" data-theme="b">Back</a>
      </div>
    </div>
    <div data-role="page" id="step1" data-theme="e">
      <div data-role="header" data-theme="b">
        <div class="ui-grid-a">
          <div class="ui-block-a custom">
            <a href="#front">
              <img src="logo-up.png" style="height: 3.8em; padding-left: 5px;" />
            </a>
          </div>
          <div class="ui-block-b custom">
            <p>3. Checklist (1/3)</p>
          </div>
        </div>
      </div>
      <div data-role="content">
        <h1>3. Checklist (1/3)</h1>
        <p>Answer the question to determine which, if any, of the indications for irradiation or CVM negative are likely to apply.</p>
        <h3>What will you transfuse?</h3>
        <ul data-role="listview" data-theme="b" data-dividertheme="a">
          <li> <a href="javascript:%20void(0);" onclick="showIndication('relative', '#step1');">1. Blood from a relative of the
            patient.</a>
          </li>
          <li> <a href="javascript:%20void(0);" onclick="showIndication('granulocytes', '#step1');">2. Granulocytes.</a>
          </li>
          <li> <a href="javascript:%20void(0);" onclick="showIndication('hla', '#step1');">3. Human Leukocyte Antigen (HLA) matched
            component.</a>
          </li>
          <li> <a href="javascript:%20void(0);" onclick="showIndication('plasma', '#step1');">4. Fresh frozen plasma, cryoprecipitate
            or fractionated plasma product.</a>
          </li>
          <li> <a href="#step2">5. None of the above</a>
          </li>
        </ul>
        <br />
        <p>Press a button to answer the question.</p>
        <br /> <a href="#front" data-theme="b" data-role="button" data-icon="arrow-l" data-iconpos="left">Main menu</a>
      </div>
    </div>
    <div data-role="page" id="step2" data-theme="e">
      <div data-role="header" data-theme="b">
        <div class="ui-grid-a">
          <div class="ui-block-a custom">
            <a href="#step1">
              <img src="logo-up.png" style="height: 3.8em; padding-left: 5px;" />
            </a>
          </div>
          <div class="ui-block-b custom">
            <p>3. Checklist (2/3)</p>
          </div>
        </div>
      </div>
      <div data-role="content">
        <div data-role="collapsible" data-collapsed="true" data-theme="b" data-content-theme="b" id="review1">
          <h3>Review your answers</h3>
          <p>You have indicated that you will transfuse:</p>
          <ul>
            <li>non-HLA-matched</li>
            <li>red cells or platelets</li>
            <li>from a donor who is unrelated to the recipient.</li>
          </ul>
          <p>If this is incorrect, please go back to the previous screen.</p>
          <div class="ui-grid-a">
            <div class="ui-block-a"> <a href="#step1" data-theme="b" data-role="button" data-icon="arrow-l" data-iconpos="left">Back</a>
            </div>
            <div class="ui-block-b"> <a href="javascript:%20void(0);" onclick="$('#review1').trigger('collapse');" data-theme="b" data-role="button" data-icon="delete" data-iconpos="right">Close</a>
            </div>
          </div>
        </div>
        <h1>3. Checklist (2/3)</h1>
        <p>Answer the question to determine which, if any, of the indications for irradiation or CVM negative are likely to apply.</p>
        <h3>Who will you transfuse?</h3>
        <ul data-role="listview" data-theme="b" data-dividertheme="a">
          <li> <a href="javascript:%20void(0);" onclick="generateSubset('neonatology', '#step2');">1. Fetus, neonate or infant.</a>
          </li>
          <li> <a href="javascript:%20void(0);" onclick="showIndication('pregnancy', '#step2');">2. Pregnant woman.</a>
          </li>
          <li> <a href="javascript:%20void(0);" onclick="generateSubset('transplant', '#step2');">3. Donor or recipient of bone
            marrow or stem cell transplant.</a>
          </li>
          <li> <a href="javascript:%20void(0);" onclick="generateSubset('cancer', '#step2');">4. Patient with history of Hodgin
            lymphoma, cancer or chemotherapy with immunesuppressive drugs.</a>
          </li>
          <li> <a href="javascript:%20void(0);" onclick="showIndication('aplastic', '#step2');">5. Patient with aplastic anaemia
            treated with ATG or Campath.</a>
          </li>
          <li> <a href="javascript:%20void(0);" onclick="showIndication('immunodeficiency', '#step2');">6. Patient with confirmed or
            suspected severe T lymphocyte immunodeficiency.</a>
          </li>
          <li> <a href="#step3">7. None of the above.</a>
          </li>
        </ul>
        <br />
        <p>Please select an answer from the list.</p><a href="#step1" data-role="button" data-icon="arrow-l" data-iconpos="left" data-theme="b">Back</a>
      </div>
    </div>
    <div data-role="page" id="step3" data-theme="e">
      <div data-role="header" data-theme="b">
        <div class="ui-grid-a">
          <div class="ui-block-a custom">
            <a href="#step1">
              <img src="logo-up.png" style="height: 3.8em; padding-left: 5px;" />
            </a>
          </div>
          <div class="ui-block-b custom">
            <p>3. Checklist (3/3)</p>
          </div>
        </div>
      </div>
      <div data-role="content">
        <div data-role="collapsible" data-collapsed="true" data-theme="b" data-content-theme="b" id="review2">
          <h3>Review your answers</h3>
          <h3>What will you transfuse?</h3>
          <p>You have indicated that you will transfuse:</p>
          <ul>
            <li>non-HLA-matched</li>
            <li>red cells or platelets</li>
            <li>from a donor who is unrelated to the recipient.</li>
          </ul>
          <h3>Who will you transfuse?</h3>
          <p>You have indicated that you will transfuse a patient who is <i><u>NOT</u></i>
            among the following risk groups:</p>
          <ul>
            <li>Fetus, neonate or infant.</li>
            <li>Pregnant woman.</li>
            <li>Donor or recipient of bone marrow or stem cell transplant.</li>
            <li>Patient with a history of Hodgin lymphoma, cancer or chemotherapy with immunesuppressive drugs.</li>
            <li>Aplasic anaemia treated with ATG or Campath.</li>
            <li>Confirmed or suspected severe T lymphocyte immunodeficiency.</li>
          </ul>
          <p>If this is incorrect, please go back to the previous screen.</p>
          <div class="ui-grid-a">
            <div class="ui-block-a"> <a href="#step2" data-theme="b" data-role="button" data-icon="arrow-l" data-iconpos="left">Back</a>
            </div>
            <div class="ui-block-b"> <a href="javascript:%20void(0);" onclick="$('#review2').trigger('collapse');" data-theme="b" data-role="button" data-icon="delete" data-iconpos="right">Close</a>
            </div>
          </div>
        </div>
        <h1>3. Checklist (3/3)</h1>
        <p>
          <strong>No indications for irradiated or CMV negative cellular blood components could be found based on your answers.</strong>
        </p>
        <p>However, it is important to remain vigilant in case the assumptions change. For example if additional medical history becomes available or incorrect information is discovered. Robust information and communication is particular challenging during shared patient care.</p>
        <h3>Thorough bedside checks</h3>
        <p>Always check if the patient has a relevant flag or note in their health record, or are in possession of a card noting special requirements.</p>
        <p>It is very important that bedside checks are completed thoroughly to ensure that the right patient receives the right blood components. This includes rigerously checking patient identity.</p>
        <h3>Leucodepletion reduces risks</h3>
        <p>All red cells and platelets supplied through the UK Blood Services are <a href="javascript:%20showWord('leucodepletion')" class="definition">leucodepleted</a>
          <a href="javascript:%20showSource('bcsh2010');" class="reference">SaBTO 2012,
          p.1</a>. This reduces the risk of CMV infection, but is not a substitute for irradiation. Take special care if leucodepleted cellular blood components are unavailable.</p>
        <p>Press the home button to return to the main menu.</p>
        <div class="ui-grid-a">
          <div class="ui-block-a"> <a href="#step2" data-theme="b" data-role="button" data-icon="arrow-l" data-iconpos="left">Back</a>
          </div>
          <div class="ui-block-b"> <a href="#front" data-theme="b" data-role="button" data-icon="arrow-r" data-iconpos="right">Home</a>
          </div>
        </div>
      </div>
    </div>
    <div data-role="page" id="quiz" data-theme="e">
      <div data-role="header" data-theme="b">
        <div class="ui-grid-a">
          <div class="ui-block-a custom">
            <a href="#front">
              <img src="logo-up.png" style="height: 3.8em; padding-left: 5px;" />
            </a>
          </div>
          <div class="ui-block-b custom">
            <p>4. Quiz</p>
          </div>
        </div>
      </div>
      <div data-role="content">
        <h1>4. Quiz</h1>
        <h2 id="quizRound"></h2>
        <h3>How should
          <span id="quizArticle"></span>
          <span id="quizQuestion"></span>
        </h3>
        <div id="quizDefinition"></div>
        <br />
        <div id="quizOptions">
          <ul data-role="listview" data-theme="b">
            <li> <a href="#" onclick="answerQuiz('irradiated-cmv')">1. Irradiated and CMV
              negative</a>
            </li>
            <li> <a href="#" onclick="answerQuiz('irradiated')">2. Irradiated</a>
            </li>
            <li> <a href="#" onclick="answerQuiz('cmv')">3. CMV negative</a>
            </li>
            <li> <a href="#" onclick="answerQuiz('normal')">4. Special component not
              required</a>
            </li>
            <li> <a href="#" onclick="answerQuiz('maybe')">5. Not enough information</a>
            </li>
          </ul>
        </div>
        <br />
        <p>Answer the question by selecting an option from the list. Only one answer is correct.</p>
        <div class="ui-grid-a">
          <div class="ui-block-a"> <a href="#" data-theme="b" data-role="button" data-icon="arrow-l" data-iconpos="left" onclick="answerQuiz('previous')">Previous</a>
          </div>
          <div class="ui-block-b"> <a href="#" data-icon="arrow-r" data-iconpos="right" onclick="answerQuiz('next')" data-theme="b" data-role="button">Next</a>
          </div>
        </div>
      </div>
    </div>
    <div data-role="page" id="about" data-theme="e">
      <div data-role="header" data-theme="b">
        <div class="ui-grid-a">
          <div class="ui-block-a custom">
            <a href="#front">
              <img src="logo-up.png" style="height: 3.8em; padding-left: 5px;" />
            </a>
          </div>
          <div class="ui-block-b custom">
            <p>About the app</p>
          </div>
        </div>
      </div>
      <div data-role="content">
        <h1>About the app</h1>
        <p> <b>Special Blood Request</b> is developed by Dr. Brian McClelland, editor of the fourth edition of the Handbook of Transfusion Medicine, and Karl Monsen, a PhD student at The University of Edinburgh.</p>
        <h2>Purpose</h2>
        <p>The app aims to make it quick and easy to learn about, look up and test your knowledge of the indications for irradiated and cytomegalovirus (CMV) negative blood components.</p>
        <h2>Design assumptions</h2>
        <p> <b>Special Blood Request</b> adhers to current UK national guidelines on irradiation <a href="javascript:%20showSource('bcsh2010')" class="reference">BCSH 2010</a> and CMV negative <a href="javascript:%20showSource('sabto2010')" class="reference">SaBTO 2010</a> blood components.</p>
        <p>It was designed to meet short term informational needs, as well as encourage deeper learning, by providing quick access to indications and information explaining the rationale behind them, what can go wrong and how to prevent mistakes.</p>
        <p>The traffic light system is used to communicate when special components are required (red), may be required (amber) or are unlikely to be required (green).</p>
        <h2>How to use the app</h2>
        <p>The app has four main sections, accessible from the main menu:</p>
        <ol class="plainlist">
          <li> <b>Information</b> - Learn about why cellular blood components need to be supplied as irradiated and CMV negative to patients at risk, and why mistakes can happen in this process.</li>
          <li> <b>Indications</b> - Find out if a patient, condition or component might require irradiated or CMV negative blood.</li>
          <li> <b>Checklist</b> - Rule out irrelevant indications based on what component is transfused to whom.</li>
          <li> <b>Quiz</b> - Test your knowledge of the indications.</li>
        </ol>
        <p>Make use of the glossary and reference sections to increase your understanding and access the original sources.</p>
        <h2>Acknowledgements</h2>
        <p>The authors would like to acknowledge the support and contributions from (in alphabetical order):</p>
        <ul class="plainlist">
          <li>Dr. Shubha Allard, Consultant Haematologist at Barts and NHS Blood and Transplant, and Chair of British Committee for Standards in Haematology.</li>
          <li>Dr. Paula Bolton-Maggs, Medical Director, Serious Hazards of Transfusion (SHOT).</li>
          <li>Mr. Amanpreet Dhesi, Regional Lead: Patient Blood Management Team, NHS Blood and Transplant (NHSBT).</li>
          <li>Dr Lise Estcourt, Research Registrar, NHSBT.</li>
          <li>Mrs. Sandra Gray, Head of Nursing (Clinical Services), The Scottish National Blood Transfusion Service (SNBTS).</li>
          <li>Dr. Alastair Nimmo, Consultant Anaesthetist, Royal Infirmary of Edinburgh.</li>
          <li>Ms. Debbi Poles, Research Analyst, SHOT.</li>
          <li>Dr. Charles Wallis, ICU Consultant, Western General Hospital Edinburgh.</li>
          <li>Ms. Alison Watts, Operations Manager, SHOT.</li>
          <li>Dr. Sharon Zahra, Consultant in Transfusion Medicine, SNBTS.</li>
        </ul><a href="#front" data-theme="b" data-role="button" data-icon="arrow-l" data-iconpos="left">Back</a>
      </div>
    </div>
    <div data-role="page" id="indication" data-theme="e">
      <div data-role="header" data-theme="b">
        <div class="ui-grid-a">
          <div class="ui-block-a custom">
            <a class="indicationBack" href="#list">
              <img src="logo-up.png" style="height: 3.8em; padding-left: 5px;" />
            </a>
          </div>
          <div class="ui-block-b custom">
            <p>2. Indications</p>
          </div>
        </div>
      </div>
      <div data-role="content">
        <h2 style="text-align: center;" id="indicationTitle">Press back to show list of indications</h2>
        <div id="overallRecommendation"></div>
        <div id="pageDefinition"></div>
        <br /> <a href="#list" data-theme="b" data-role="button" data-icon="arrow-l" data-iconpos="left" class="indicationBack">Back</a>
      </div>
    </div>
    <div data-role="page" id="quizAnswer" data-theme="e">
      <div data-role="header" data-theme="b">
        <div class="ui-grid-a">
          <div class="ui-block-a custom">
            <a href="#front">
              <img src="logo-up.png" style="height: 3.8em; padding-left: 5px;" />
            </a>
          </div>
          <div class="ui-block-b custom">
            <p>4. Quiz</p>
          </div>
        </div>
      </div>
      <div data-role="content">
        <h2 id="quizTitle"></h2>
        <h3 id="quizVerdict">Press next question to show a question.</h3>
        <p id="quizCorrect"></p>
        <div id="quizRecommendation" style="display: none; text-align: center; border: 2px dotted #000;"></div><a href="#" data-theme="b" data-icon="arrow-r" data-iconpos="right" data-rel="back" data-role="button">Next question</a>
      </div>
    </div>
    <p style="text-align: center;font-family: arial, sans-serif; font-size:15px;">We're listening! Please take a moment to leave feedback.
      <br />
      <br /> <a href="javascript:openEvaluation();" id="evaluationButton">Leave
      feedback!</a>
    </p>
    <br />
  </body>

</html>